| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 1.64e-07 | 38 | 219 | 7 | GO:0000146 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 1.75e-05 | 15 | 219 | 4 | GO:0004029 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 3.00e-05 | 17 | 219 | 4 | GO:0004030 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.79e-05 | 118 | 219 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1E1 MYH9 MYH10 MYH11 ATP6V0A1 MYO1D ACSL1 ACSM3 ABCC8 DNAH5 MYH7B WRN ABCC9 MSH2 MORC4 ACSM4 MYH14 MYO1F ATP5F1A | 4.99e-05 | 614 | 219 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity | 1.04e-04 | 9 | 219 | 3 | GO:0043878 | |
| GeneOntologyMolecularFunction | protein-glutamine gamma-glutamyltransferase activity | 1.04e-04 | 9 | 219 | 3 | GO:0003810 | |
| GeneOntologyMolecularFunction | histidine-tRNA ligase activity | 1.20e-04 | 2 | 219 | 2 | GO:0004821 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor activity | 1.20e-04 | 2 | 219 | 2 | GO:0008281 | |
| GeneOntologyMolecularFunction | ADP binding | 1.77e-04 | 48 | 219 | 5 | GO:0043531 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.13e-04 | 227 | 219 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 6.38e-04 | 172 | 219 | 8 | GO:0044325 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | UAP1 LRRK2 PFKL STK35 GK PIK3CB FGFR2 PRIMPOL RPS6KA4 FKRP MAP4K3 MINK1 YES1 MAP3K6 CDK10 PALS1 TRIB3 GUCY2C PDIK1L MAP4K5 CDK11B EPHA10 | 6.70e-04 | 938 | 219 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | ligase activity | 6.88e-04 | 174 | 219 | 8 | GO:0016874 | |
| GeneOntologyMolecularFunction | kinase activity | LRRK2 PFKL STK35 GK PIK3CB FGFR2 RPS6KA4 MAP4K3 MINK1 YES1 MAP3K6 CDK10 PALS1 TRIB3 GUCY2C PDIK1L MAP4K5 CDK11B EPHA10 | 7.89e-04 | 764 | 219 | 19 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | LRRK2 PFKL STK35 GK PIK3CB FGFR2 RPS6KA4 MAP4K3 MINK1 YES1 MAP3K6 CDK10 TRIB3 GUCY2C PDIK1L MAP4K5 CDK11B EPHA10 | 8.58e-04 | 709 | 219 | 18 | GO:0016773 |
| GeneOntologyMolecularFunction | actin binding | MYH9 MYH10 MYH11 MYO1D SPTB LRRK2 HDAC6 MYH7B MYRIP MYH14 MYO1F NEXN HCLS1 MYBPC3 | 8.66e-04 | 479 | 219 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | protein kinase activity | LRRK2 STK35 PIK3CB FGFR2 RPS6KA4 MAP4K3 MINK1 YES1 MAP3K6 CDK10 TRIB3 GUCY2C PDIK1L MAP4K5 CDK11B EPHA10 | 9.98e-04 | 600 | 219 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | calmodulin binding | 1.02e-03 | 230 | 219 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential | 1.17e-03 | 5 | 219 | 2 | GO:0099530 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CHL1 MYH9 MYH10 VPS33A LRRK2 CDH23 TTC3 GRHL2 TENM2 RNF157 TUBB3 FAT1 PTPRF NEGR1 PCDH15 FGFR2 CFAP70 DNMBP SLC23A2 PLXNB1 CPNE9 HDAC6 FN1 PACSIN1 MINK1 ZDHHC17 TECTA ATL1 THBS4 CELSR3 MYH14 ROBO1 SMN1 CFAP44 NEXN CDH9 PACSIN2 EPHA10 EPB42 SEMA3E | 7.12e-11 | 1194 | 218 | 40 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron development | CHL1 CFH DLG5 MYH10 LRRK2 CDH23 TTC3 CSMD3 TENM2 RNF157 TUBB3 BTG2 PTPRF PTPRG NEGR1 PCDH15 MTMR2 FGFR2 SLC23A2 SDK1 PLXNB1 CPNE9 HDAC6 FN1 PACSIN1 MINK1 CEP290 ZDHHC17 TECTA ATL1 EFHC2 PALS1 THBS4 CELSR3 ROBO1 SMN1 NEXN EPHA10 SEMA3E | 7.44e-08 | 1463 | 218 | 39 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CHL1 MYH10 LRRK2 TTC3 TENM2 RNF157 TUBB3 PTPRF NEGR1 FGFR2 SLC23A2 PLXNB1 CPNE9 HDAC6 FN1 PACSIN1 MINK1 ZDHHC17 ATL1 THBS4 CELSR3 ROBO1 SMN1 NEXN PACSIN2 EPHA10 SEMA3E | 2.01e-07 | 826 | 218 | 27 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron projection development | CHL1 DLG5 MYH10 LRRK2 CDH23 TTC3 CSMD3 TENM2 RNF157 TUBB3 BTG2 PTPRF PTPRG NEGR1 PCDH15 FGFR2 SLC23A2 SDK1 PLXNB1 CPNE9 HDAC6 FN1 PACSIN1 MINK1 ZDHHC17 TECTA ATL1 EFHC2 THBS4 CELSR3 ROBO1 SMN1 NEXN EPHA10 SEMA3E | 2.33e-07 | 1285 | 218 | 35 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CHL1 MYH10 LRRK2 TTC3 TENM2 RNF157 TUBB3 PTPRF NEGR1 FGFR2 SLC23A2 PLXNB1 CPNE9 HDAC6 FN1 PACSIN1 MINK1 ZDHHC17 ATL1 THBS4 CELSR3 ROBO1 SMN1 NEXN EPHA10 SEMA3E | 4.04e-07 | 802 | 218 | 26 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CHL1 MYH10 LRRK2 TTC3 TENM2 RNF157 TUBB3 PTPRF NEGR1 FGFR2 SLC23A2 PLXNB1 CPNE9 HDAC6 FN1 PACSIN1 MINK1 ZDHHC17 ATL1 THBS4 CELSR3 ROBO1 SMN1 NEXN EPHA10 SEMA3E | 6.01e-07 | 819 | 218 | 26 | GO:0120039 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CHL1 CDH23 FAT1 PTPRF PTPRG PIK3CB PCDH15 SDK1 CELSR3 ROBO1 NEXN CDH9 | 7.55e-07 | 187 | 218 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CHL1 MYH10 LRRK2 CDH23 TTC3 TENM2 TUBB3 PTPRF PCDH15 FGFR2 PLXNB1 HDAC6 FN1 MINK1 ZDHHC17 TECTA ATL1 CELSR3 ROBO1 SMN1 NEXN EPHA10 SEMA3E | 4.76e-06 | 748 | 218 | 23 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | MYH9 MYH10 RNF157 PTPRF DNMBP SLC23A2 PLXNB1 CPNE9 HDAC6 FN1 MYH14 EPB42 SEMA3E | 2.11e-05 | 302 | 218 | 13 | GO:0022604 |
| GeneOntologyBiologicalProcess | amino-acid betaine biosynthetic process | 2.28e-05 | 6 | 218 | 3 | GO:0006578 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CHL1 CDH23 TENM2 FAT1 PTPRF PTPRG PIK3CB PCDH15 SDK1 CELSR3 ROBO1 NEXN CDH9 | 3.07e-05 | 313 | 218 | 13 | GO:0098742 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.73e-05 | 153 | 218 | 9 | GO:0030048 | |
| GeneOntologyBiologicalProcess | cell junction organization | DLG5 MYH9 MYH10 SPTB LRRK2 GRHL2 PTPRF NEGR1 ABCC8 MTMR2 FGFR2 MARVELD3 VSTM5 SDK1 PLXNB1 HDAC6 FN1 FKRP GJC1 ZDHHC17 GRM5 ACE2 ROBO1 CDH9 SEMA3E | 3.91e-05 | 974 | 218 | 25 | GO:0034330 |
| GeneOntologyBiologicalProcess | spliceosomal complex assembly | 8.74e-05 | 99 | 218 | 7 | GO:0000245 | |
| GeneOntologyBiologicalProcess | histidyl-tRNA aminoacylation | 1.11e-04 | 2 | 218 | 2 | GO:0006427 | |
| GeneOntologyBiologicalProcess | glycine betaine metabolic process | 1.11e-04 | 2 | 218 | 2 | GO:0031455 | |
| GeneOntologyBiologicalProcess | glycine betaine biosynthetic process | 1.11e-04 | 2 | 218 | 2 | GO:0031456 | |
| GeneOntologyBiologicalProcess | glycine betaine biosynthetic process from choline | 1.11e-04 | 2 | 218 | 2 | GO:0019285 | |
| GeneOntologyBiologicalProcess | axonogenesis | CHL1 MYH10 TTC3 TENM2 TUBB3 FGFR2 PLXNB1 HDAC6 FN1 ZDHHC17 ATL1 CELSR3 ROBO1 SMN1 NEXN EPHA10 SEMA3E | 1.15e-04 | 566 | 218 | 17 | GO:0007409 |
| GeneOntologyBiologicalProcess | erythrocyte maturation | 1.51e-04 | 26 | 218 | 4 | GO:0043249 | |
| GeneOntologyBiologicalProcess | axon development | CHL1 MYH10 TTC3 TENM2 TUBB3 PTPRF FGFR2 PLXNB1 HDAC6 FN1 ZDHHC17 ATL1 CELSR3 ROBO1 SMN1 NEXN EPHA10 SEMA3E | 1.71e-04 | 642 | 218 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | peptide cross-linking | 1.76e-04 | 27 | 218 | 4 | GO:0018149 | |
| GeneOntologyBiologicalProcess | otic vesicle morphogenesis | 2.39e-04 | 12 | 218 | 3 | GO:0071600 | |
| GeneOntologyBiologicalProcess | righting reflex | 2.39e-04 | 12 | 218 | 3 | GO:0060013 | |
| GeneOntologyBiologicalProcess | determination of adult lifespan | 2.61e-04 | 54 | 218 | 5 | GO:0008340 | |
| GeneOntologyBiologicalProcess | embryo development | MYH9 MYH10 CDH23 STOX1 GRHL2 PIK3CB SUV39H1 PCDH15 FGFR2 DMBT1 ALDH1A3 SRSF1 FN1 FKRP FLVCR1 CEP290 MSH2 CUBN TECTA PAF1 TDRD1 TDRD7 PALS1 SF3B1 CELF1 KIAA1217 SF3B6 RBPJ CDK11B ATP5F1A | 2.72e-04 | 1437 | 218 | 30 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of cell shape | 2.96e-04 | 159 | 218 | 8 | GO:0008360 | |
| GeneOntologyBiologicalProcess | prostate epithelial cord elongation | 3.31e-04 | 3 | 218 | 2 | GO:0060523 | |
| GeneOntologyBiologicalProcess | actin filament bundle distribution | 3.31e-04 | 3 | 218 | 2 | GO:0070650 | |
| GeneOntologyCellularComponent | myosin filament | 1.80e-07 | 25 | 218 | 6 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II filament | 1.12e-06 | 3 | 218 | 3 | GO:0097513 | |
| GeneOntologyCellularComponent | axon | CFH MYH10 MYO1D ESR1 LRRK2 TENM2 TUBB3 PTPRF KCNC1 MTMR2 VSTM5 EXOC6 HDAC6 PACSIN1 MINK1 GRIK3 ATL1 MADD PALS1 MYH14 ROBO1 SMN1 IL1R1 NEXN CDH9 GABBR1 | 2.24e-06 | 891 | 218 | 26 | GO:0030424 |
| GeneOntologyCellularComponent | myosin complex | 2.62e-06 | 59 | 218 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin II complex | 9.52e-06 | 28 | 218 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | axolemma | 5.99e-05 | 21 | 218 | 4 | GO:0030673 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.23e-04 | 223 | 218 | 10 | GO:0098862 | |
| GeneOntologyCellularComponent | cell cortex | MYH9 MYH10 MYO1D SPTB STOX1 RYR1 FABP2 FGFR2 EXOC6 MYRIP MYO1F HCLS1 EPB42 | 1.50e-04 | 371 | 218 | 13 | GO:0005938 |
| GeneOntologyCellularComponent | actin-based cell projection | ATP6V1E1 MYO1D LRRK2 CDH23 TENM2 FABP2 TUBB3 FAT1 PCDH15 CUBN MYO1F | 1.71e-04 | 278 | 218 | 11 | GO:0098858 |
| GeneOntologyCellularComponent | brush border | 1.99e-04 | 152 | 218 | 8 | GO:0005903 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CHL1 CFH MYH10 URI1 MYO1D ESR1 LRRK2 PDE10A TENM2 TUBB3 PTPRF KCNC1 NEGR1 SV2A MTMR2 VSTM5 HDAC6 MINK1 GRIK3 GRM5 ARG1 PALS1 ROBO1 SMN1 CDH9 EPHA10 GABBR1 | 2.03e-04 | 1228 | 218 | 27 | GO:0036477 |
| GeneOntologyCellularComponent | glial limiting end-foot | 3.23e-04 | 3 | 218 | 2 | GO:0097451 | |
| GeneOntologyCellularComponent | potassium ion-transporting ATPase complex | 3.23e-04 | 3 | 218 | 2 | GO:0031004 | |
| GeneOntologyCellularComponent | inward rectifying potassium channel | 6.41e-04 | 4 | 218 | 2 | GO:0008282 | |
| GeneOntologyCellularComponent | dendrite | CHL1 MYH10 URI1 MYO1D LRRK2 TENM2 TUBB3 KCNC1 NEGR1 SV2A MTMR2 VSTM5 HDAC6 MINK1 GRIK3 GRM5 ROBO1 CDH9 EPHA10 GABBR1 | 6.89e-04 | 858 | 218 | 20 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CHL1 MYH10 URI1 MYO1D LRRK2 TENM2 TUBB3 KCNC1 NEGR1 SV2A MTMR2 VSTM5 HDAC6 MINK1 GRIK3 GRM5 ROBO1 CDH9 EPHA10 GABBR1 | 7.09e-04 | 860 | 218 | 20 | GO:0097447 |
| GeneOntologyCellularComponent | site of polarized growth | 1.40e-03 | 253 | 218 | 9 | GO:0030427 | |
| GeneOntologyCellularComponent | cell-cell junction | DLG5 MYH9 GRHL2 TENM2 FAT1 SV2A MARVELD3 DNMBP THEMIS GJC1 TGM1 PALS1 NEXN CDH9 PACSIN2 | 1.42e-03 | 591 | 218 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | apical part of cell | CHL1 ATP6V1E1 MYH9 SLC36A1 CDH23 FABP2 FAT1 SCNN1G SLC23A2 FN1 MYRIP CUBN ACE2 PALS1 SLC15A2 | 1.44e-03 | 592 | 218 | 15 | GO:0045177 |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 1.69e-03 | 49 | 218 | 4 | GO:0090533 | |
| GeneOntologyCellularComponent | microvillus | 1.85e-03 | 123 | 218 | 6 | GO:0005902 | |
| GeneOntologyCellularComponent | distal axon | MYH10 ESR1 LRRK2 TENM2 TUBB3 PTPRF KCNC1 EXOC6 PACSIN1 GRIK3 MYH14 SMN1 | 2.14e-03 | 435 | 218 | 12 | GO:0150034 |
| GeneOntologyCellularComponent | astrocyte projection | 2.17e-03 | 25 | 218 | 3 | GO:0097449 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 2.36e-03 | 129 | 218 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | cell leading edge | MYH9 MYH10 MYO1D TUBB3 FAT1 KCNC1 HDAC6 PACSIN1 INPP5E ROBO1 ARHGAP45 PACSIN2 GABBR1 | 2.37e-03 | 500 | 218 | 13 | GO:0031252 |
| GeneOntologyCellularComponent | precatalytic spliceosome | 2.42e-03 | 54 | 218 | 4 | GO:0071011 | |
| GeneOntologyCellularComponent | perikaryon | 2.43e-03 | 223 | 218 | 8 | GO:0043204 | |
| Domain | Myosin_head_motor_dom | 2.57e-07 | 38 | 219 | 7 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.57e-07 | 38 | 219 | 7 | PS51456 | |
| Domain | Myosin_head | 2.57e-07 | 38 | 219 | 7 | PF00063 | |
| Domain | MYSc | 2.57e-07 | 38 | 219 | 7 | SM00242 | |
| Domain | Myosin_N | 5.78e-07 | 15 | 219 | 5 | PF02736 | |
| Domain | Myosin_N | 5.78e-07 | 15 | 219 | 5 | IPR004009 | |
| Domain | Myosin_tail_1 | 1.60e-06 | 18 | 219 | 5 | PF01576 | |
| Domain | Myosin_tail | 1.60e-06 | 18 | 219 | 5 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 2.15e-06 | 19 | 219 | 5 | IPR027401 | |
| Domain | - | 2.15e-06 | 19 | 219 | 5 | 4.10.270.10 | |
| Domain | - | CHL1 F13A1 PTPRF PTPRG PIGR NEGR1 FGFR2 VSTM5 SDK1 PLXNB1 IGSF3 MXRA5 FN1 TGM1 RBPJ ROBO1 IL1R1 NEXN EPHA10 EPB42 LRIT1 SEMA3E MYBPC3 | 3.55e-06 | 663 | 219 | 23 | 2.60.40.10 |
| Domain | Ig-like_fold | CHL1 F13A1 PTPRF PTPRG PIGR NEGR1 FGFR2 VSTM5 SDK1 PLXNB1 IGSF3 MXRA5 FN1 TGM1 RBPJ ROBO1 IL1R1 NEXN EPHA10 EPB42 LRIT1 SEMA3E MYBPC3 | 9.92e-06 | 706 | 219 | 23 | IPR013783 |
| Domain | Ig_I-set | CHL1 PTPRF NEGR1 FGFR2 SDK1 MXRA5 ROBO1 IL1R1 NEXN LRIT1 MYBPC3 | 1.56e-05 | 190 | 219 | 11 | IPR013098 |
| Domain | I-set | CHL1 PTPRF NEGR1 FGFR2 SDK1 MXRA5 ROBO1 IL1R1 NEXN LRIT1 MYBPC3 | 1.56e-05 | 190 | 219 | 11 | PF07679 |
| Domain | Ald_DH_CS_GLU | 3.00e-05 | 16 | 219 | 4 | IPR029510 | |
| Domain | Ald_DH_CS_CYS | 3.88e-05 | 17 | 219 | 4 | IPR016160 | |
| Domain | IQ | 4.61e-05 | 81 | 219 | 7 | SM00015 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 4.95e-05 | 18 | 219 | 4 | PS00070 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 4.95e-05 | 18 | 219 | 4 | PS00687 | |
| Domain | - | 6.21e-05 | 19 | 219 | 4 | 3.40.605.10 | |
| Domain | Aldedh | 6.21e-05 | 19 | 219 | 4 | PF00171 | |
| Domain | Ald_DH_C | 6.21e-05 | 19 | 219 | 4 | IPR016163 | |
| Domain | Ald_DH_N | 6.21e-05 | 19 | 219 | 4 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 6.21e-05 | 19 | 219 | 4 | IPR016161 | |
| Domain | Aldehyde_DH_dom | 6.21e-05 | 19 | 219 | 4 | IPR015590 | |
| Domain | - | 6.21e-05 | 19 | 219 | 4 | 3.40.309.10 | |
| Domain | IQ_motif_EF-hand-BS | 9.07e-05 | 90 | 219 | 7 | IPR000048 | |
| Domain | IQ | 1.12e-04 | 93 | 219 | 7 | PS50096 | |
| Domain | Transglut_N | 1.27e-04 | 9 | 219 | 3 | PF00868 | |
| Domain | TRANSGLUTAMINASES | 1.27e-04 | 9 | 219 | 3 | PS00547 | |
| Domain | - | 1.27e-04 | 9 | 219 | 3 | 3.90.260.10 | |
| Domain | Gln_gamma-glutamylTfrase_euk | 1.27e-04 | 9 | 219 | 3 | IPR023608 | |
| Domain | Transglutaminase_AS | 1.27e-04 | 9 | 219 | 3 | IPR013808 | |
| Domain | Transglutaminase_N | 1.27e-04 | 9 | 219 | 3 | IPR001102 | |
| Domain | Transglut_C | 1.27e-04 | 9 | 219 | 3 | PF00927 | |
| Domain | fn3 | 1.28e-04 | 162 | 219 | 9 | PF00041 | |
| Domain | TUDOR | 1.37e-04 | 23 | 219 | 4 | PS50304 | |
| Domain | His-tRNA-ligase | 1.37e-04 | 2 | 219 | 2 | IPR015807 | |
| Domain | HisRS_anticodon | 1.37e-04 | 2 | 219 | 2 | IPR033656 | |
| Domain | Sulphorea_rcpt | 1.37e-04 | 2 | 219 | 2 | IPR000388 | |
| Domain | HisRS/HisZ | 1.37e-04 | 2 | 219 | 2 | IPR004516 | |
| Domain | IG | CHL1 PTPRF PIGR NEGR1 FGFR2 VSTM5 SDK1 IGSF3 MXRA5 ROBO1 IL1R1 NEXN LRIT1 SEMA3E MYBPC3 | 1.41e-04 | 421 | 219 | 15 | SM00409 |
| Domain | Ig_sub | CHL1 PTPRF PIGR NEGR1 FGFR2 VSTM5 SDK1 IGSF3 MXRA5 ROBO1 IL1R1 NEXN LRIT1 SEMA3E MYBPC3 | 1.41e-04 | 421 | 219 | 15 | IPR003599 |
| Domain | Transglutaminase_C | 1.80e-04 | 10 | 219 | 3 | IPR008958 | |
| Domain | IQ | 1.84e-04 | 71 | 219 | 6 | PF00612 | |
| Domain | Prot_kinase_dom | LRRK2 STK35 FGFR2 MARVELD3 RPS6KA4 MAP4K3 MINK1 YES1 MAP3K6 CDK10 TRIB3 GUCY2C PDIK1L MAP4K5 CDK11B EPHA10 | 2.23e-04 | 489 | 219 | 16 | IPR000719 |
| Domain | Transglutaminase-like | 2.45e-04 | 11 | 219 | 3 | IPR002931 | |
| Domain | TGc | 2.45e-04 | 11 | 219 | 3 | SM00460 | |
| Domain | Transglut_core | 2.45e-04 | 11 | 219 | 3 | PF01841 | |
| Domain | TUDOR | 2.61e-04 | 27 | 219 | 4 | SM00333 | |
| Domain | FN3 | 3.44e-04 | 185 | 219 | 9 | SM00060 | |
| Domain | Tudor | 3.97e-04 | 30 | 219 | 4 | IPR002999 | |
| Domain | IGc2 | 4.72e-04 | 235 | 219 | 10 | SM00408 | |
| Domain | Ig_sub2 | 4.72e-04 | 235 | 219 | 10 | IPR003598 | |
| Domain | TUDOR | 5.26e-04 | 14 | 219 | 3 | PF00567 | |
| Domain | CNH | 5.26e-04 | 14 | 219 | 3 | SM00036 | |
| Domain | FN3 | 5.84e-04 | 199 | 219 | 9 | PS50853 | |
| Domain | CNH | 6.52e-04 | 15 | 219 | 3 | PF00780 | |
| Domain | CNH | 6.52e-04 | 15 | 219 | 3 | PS50219 | |
| Domain | CNH_dom | 6.52e-04 | 15 | 219 | 3 | IPR001180 | |
| Domain | Kinase-like_dom | LRRK2 STK35 PIK3CB FGFR2 RPS6KA4 MAP4K3 MINK1 YES1 MAP3K6 CDK10 TRIB3 GUCY2C PDIK1L MAP4K5 CDK11B EPHA10 | 6.87e-04 | 542 | 219 | 16 | IPR011009 |
| Domain | PROTEIN_KINASE_DOM | LRRK2 STK35 FGFR2 RPS6KA4 MAP4K3 MINK1 YES1 MAP3K6 CDK10 TRIB3 GUCY2C PDIK1L MAP4K5 CDK11B EPHA10 | 7.43e-04 | 493 | 219 | 15 | PS50011 |
| Domain | MAPKKKK | 8.09e-04 | 4 | 219 | 2 | IPR021160 | |
| Domain | FN3_dom | 8.29e-04 | 209 | 219 | 9 | IPR003961 | |
| Domain | ANF_lig-bd_rcpt | 8.97e-04 | 37 | 219 | 4 | IPR001828 | |
| Domain | ANF_receptor | 8.97e-04 | 37 | 219 | 4 | PF01094 | |
| Domain | Ig-like_dom | CHL1 PTPRF PIGR NEGR1 FGFR2 VSTM5 SDK1 IGSF3 MXRA5 ROBO1 IL1R1 NEXN LRIT1 SEMA3E MYBPC3 | 9.10e-04 | 503 | 219 | 15 | IPR007110 |
| Domain | SH3 | 1.05e-03 | 216 | 219 | 9 | SM00326 | |
| Domain | SH3 | 1.05e-03 | 216 | 219 | 9 | PS50002 | |
| Domain | Peripla_BP_I | 1.10e-03 | 39 | 219 | 4 | IPR028082 | |
| Domain | aa-tRNA-synth_II | 1.14e-03 | 18 | 219 | 3 | IPR006195 | |
| Domain | AA_TRNA_LIGASE_II | 1.14e-03 | 18 | 219 | 3 | PS50862 | |
| Domain | SH3_domain | 1.19e-03 | 220 | 219 | 9 | IPR001452 | |
| Domain | Myosin_S1_N | 1.34e-03 | 5 | 219 | 2 | IPR008989 | |
| Domain | 3'-5'_exonuclease_dom | 1.34e-03 | 5 | 219 | 2 | IPR002562 | |
| Domain | 35EXOc | 1.34e-03 | 5 | 219 | 2 | SM00474 | |
| Domain | DNA_pol_A_exo1 | 1.34e-03 | 5 | 219 | 2 | PF01612 | |
| Domain | Pkinase | LRRK2 STK35 RPS6KA4 MAP4K3 MINK1 MAP3K6 CDK10 TRIB3 GUCY2C PDIK1L MAP4K5 CDK11B | 1.87e-03 | 381 | 219 | 12 | PF00069 |
| Domain | IG_LIKE | CHL1 PTPRF PIGR NEGR1 FGFR2 SDK1 IGSF3 MXRA5 ROBO1 IL1R1 NEXN LRIT1 SEMA3E MYBPC3 | 2.04e-03 | 491 | 219 | 14 | PS50835 |
| Domain | FCH | 2.08e-03 | 22 | 219 | 3 | SM00055 | |
| Domain | FCH_dom | 2.37e-03 | 23 | 219 | 3 | IPR001060 | |
| Domain | CUB | 2.58e-03 | 49 | 219 | 4 | PF00431 | |
| Domain | Myosin_TH1 | 2.76e-03 | 7 | 219 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 2.76e-03 | 7 | 219 | 2 | IPR010926 | |
| Domain | TH1 | 2.76e-03 | 7 | 219 | 2 | PS51757 | |
| Domain | CUB | 2.78e-03 | 50 | 219 | 4 | SM00042 | |
| Domain | F_BAR | 3.02e-03 | 25 | 219 | 3 | IPR031160 | |
| Domain | F_BAR | 3.02e-03 | 25 | 219 | 3 | PS51741 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 9.57e-07 | 29 | 167 | 6 | M27309 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 2.95e-06 | 20 | 167 | 5 | M18415 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 7.78e-06 | 24 | 167 | 5 | M2243 | |
| Pathway | KEGG_BUTANOATE_METABOLISM | 4.63e-05 | 34 | 167 | 5 | M3397 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 5.21e-05 | 82 | 167 | 7 | M1021 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 6.41e-05 | 19 | 167 | 4 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 6.41e-05 | 19 | 167 | 4 | M27489 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 9.72e-05 | 21 | 167 | 4 | M27494 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.07e-04 | 64 | 167 | 6 | M7923 | |
| Pathway | WP_INSULIN_SIGNALING | 1.21e-04 | 160 | 167 | 9 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 1.21e-04 | 160 | 167 | 9 | M39482 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.41e-04 | 23 | 167 | 4 | MM15222 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.74e-04 | 132 | 167 | 8 | M11355 | |
| Pathway | KEGG_LIMONENE_AND_PINENE_DEGRADATION | 1.84e-04 | 10 | 167 | 3 | M17395 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 2.78e-04 | 76 | 167 | 6 | MM15442 | |
| Pathway | KEGG_HISTIDINE_METABOLISM | 3.58e-04 | 29 | 167 | 4 | M12524 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_RECYCLING | 4.09e-04 | 30 | 167 | 4 | M506 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_RECYCLING | 4.66e-04 | 31 | 167 | 4 | MM15467 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | HGD ATP6V1E1 MYH9 ATP6V0A1 MYO1D LRRK2 PFKL RYR1 FAT1 GK BTG2 PIGR ALDH2 CFAP70 ALDH9A1 MXRA5 FN1 MINK1 CUBN TECTA GSS ACE2 PALS1 VPS13D SLC15A2 MYH14 CTSD ATP5F1A PACSIN2 | 1.48e-11 | 1016 | 220 | 29 | 19056867 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CHL1 CFH HGD MYH9 MYH10 MYH11 ATP6V0A1 MYO1D NAGA ADGRG1 ITIH1 IGLV3-21 TUBB3 PTPRG PIGR ALDH1A3 ALDH9A1 CPNE9 FN1 XPNPEP1 CUBN GSS ACE2 PALS1 THBS4 CTSD ATP5F1A ALDH7A1 | 2.47e-10 | 1070 | 220 | 28 | 23533145 |
| Pubmed | ATP6V1E1 MYH9 MYH10 MYH11 ATP6V0A1 MYO1D VPS45 SPTB PFKL TUBB3 NEGR1 SV2A MTMR2 ALDH2 ARHGAP21 SRSF1 FN1 PACSIN1 MAP4K3 MINK1 GRM5 MADD TGM1 THBS4 SF3B1 MYH14 EIF2S1 KIAA1217 MRPL48 ATP5F1A ALDH7A1 | 2.41e-09 | 1431 | 220 | 31 | 37142655 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DLG5 ATP6V1E1 MYH9 UAP1 MYH10 RPN2 NAGA KDM3B PFKL RRAGC IGLV3-21 SF3A3 CLUH EXOSC4 PDPR HDAC6 PUF60 XPNPEP1 YES1 GSS ARG1 TGM1 SF3B1 LMNB1 SF3B6 ALG3 NEXN ATP5F1A ALDH7A1 | 1.32e-08 | 1367 | 220 | 29 | 32687490 |
| Pubmed | MYH9 MYH10 MYH11 MYO1D PFKL ALDH2 ALDH1A3 MAP4K3 ARG1 TGM1 LMNB1 MYH14 CTSD ATP5F1A | 2.63e-08 | 327 | 220 | 14 | 31409639 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 MYH10 PFKL ACSL1 TUBB3 SF3A3 ANKRD28 ALDH9A1 SRSF1 HDAC6 FN1 MAP4K3 GNPNAT1 MSH2 FAM83H ARG1 TGM1 METTL13 SF3B1 LMNB1 MYH14 EIF2S1 MAP4K5 SF3B6 CTSD NEXN ATP5F1A ALDH7A1 | 4.04e-08 | 1353 | 220 | 28 | 29467282 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DLG5 MYH9 MYH10 MYO1D RPN2 PFKL SF3A3 ZNF598 EXOSC4 SRSF1 RPS6KA4 PUF60 MSH2 FAM83H ARG1 PALS1 HARS2 SF3B1 LMNB1 EIF2S1 KIAA1217 GATAD1 GAN SMN1 CTSD ATP5F1A | 1.30e-07 | 1257 | 220 | 26 | 36526897 |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | MYH10 MYO1D FN1 YES1 METTL13 SF3B1 TRIB3 LMNB1 MYH14 EIF2S1 KIAA1217 ATP5F1A | 1.40e-07 | 264 | 220 | 12 | 32814769 |
| Pubmed | 1.71e-07 | 95 | 220 | 8 | 33863777 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | CFH DNAJB12 MYH9 ATP6V0A1 RPN2 NAGA ADGRG1 FAT1 PTPRF NEGR1 ARHGAP21 NENF PLXNB1 IGSF3 ENTPD7 NEMP1 ITGA11 FKRP H6PD MADD CELSR3 DPY19L4 ROBO1 ALG3 CTSD | 2.05e-07 | 1201 | 220 | 25 | 35696571 |
| Pubmed | UAP1 ATP6V0A1 KLHL28 KDM3B METAP1D TUBB3 ACSM3 SUV39H1 ARIH2 MTMR2 DNAH5 RPS6KA4 MAP4K3 YES1 CDK10 TGM1 HARS2 CDK11B HARS1 | 2.42e-07 | 730 | 220 | 19 | 34857952 | |
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 20685736 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 15177565 | ||
| Pubmed | Characterization of three full-length human nonmuscle myosin II paralogs. | 2.50e-07 | 3 | 220 | 3 | 24072716 | |
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 15774463 | ||
| Pubmed | Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family. | 2.50e-07 | 3 | 220 | 3 | 14594953 | |
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 15845534 | ||
| Pubmed | 3.56e-07 | 187 | 220 | 10 | 26460568 | ||
| Pubmed | DLG5 CDH23 STN1 PCDH15 FGFR2 CFAP70 DMBT1 DNMBP ARHGAP21 EXOC6 XPNPEP1 CUBN TDRD1 LRIT1 | 4.82e-07 | 415 | 220 | 14 | 16385451 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | ATP6V1E1 MYH10 MYH11 ATP6V0A1 SPTB PFKL ITIH1 ACSL1 TUBB3 SF3A3 ALDH2 MINK1 ABCC9 ATL1 LMNB1 ATP5F1A PACSIN2 | 5.33e-07 | 621 | 220 | 17 | 22794259 |
| Pubmed | Identification of FBXO25-interacting proteins using an integrated proteomics approach. | 6.10e-07 | 112 | 220 | 8 | 20473970 | |
| Pubmed | TDRD15 MYH9 VPS45 LRRK2 KDM3B FAT1 ANKRD28 SDK1 ARHGAP21 IGSF3 FN1 FLVCR1 MINK1 WRN SF3B1 LMNB1 ROBO1 ZFHX3 ATP5F1A | 6.18e-07 | 777 | 220 | 19 | 35844135 | |
| Pubmed | 7.41e-07 | 12 | 220 | 4 | 8424456 | ||
| Pubmed | Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping. | 9.94e-07 | 4 | 220 | 3 | 18697221 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | DLG5 ATP6V1E1 SPTB PFKL TTC3 ITIH1 RYR1 ALDH2 ALDH9A1 ANXA9 ARHGAP21 PUF60 WRN YES1 LMNB1 MYH14 KIAA1217 HARS1 | 1.14e-06 | 732 | 220 | 18 | 34732716 |
| Pubmed | 1.20e-06 | 54 | 220 | 6 | 22266860 | ||
| Pubmed | Patterning and folding of intestinal villi by active mesenchymal dewetting. | 2.01e-06 | 15 | 220 | 4 | 38781967 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ATP6V1E1 MYH9 KDM3B PFKL TUBB3 ARIH2 MTMR2 SF3A3 ANKRD28 ALDH9A1 DNMBP CLUH EXOSC4 PUF60 MSH2 XPNPEP1 PAF1 TSEN2 GSS LMNB1 MYH14 EIF2S1 PRKAR1B HARS1 PACSIN2 ALDH7A1 | 2.02e-06 | 1455 | 220 | 26 | 22863883 |
| Pubmed | 2.32e-06 | 34 | 220 | 5 | 12234937 | ||
| Pubmed | Myosin II regulates extension, growth and patterning in the mammalian cochlear duct. | 2.47e-06 | 5 | 220 | 3 | 19439495 | |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 9299440 | ||
| Pubmed | Telokin expression is restricted to smooth muscle tissues during mouse development. | 2.47e-06 | 5 | 220 | 3 | 11121372 | |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 33871354 | ||
| Pubmed | Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption. | 2.47e-06 | 5 | 220 | 3 | 25006807 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | MYH9 MYH10 MYH11 CDH23 TUBB3 CPNE9 VPS13D SF3B1 MYH14 EIF2S1 | 2.83e-06 | 235 | 220 | 10 | 30258100 |
| Pubmed | MYH9 MYH10 MYO1D RPN2 TUBB3 SRSF1 FN1 SF3B1 LMNB1 MYH14 EIF2S1 SMN1 ATP5F1A | 3.29e-06 | 421 | 220 | 13 | 34650049 | |
| Pubmed | 3.30e-06 | 64 | 220 | 6 | 36636478 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | FAT1 PTPRF PTPRG ARHGAP21 PLXNB1 IGSF3 FLVCR1 MINK1 GJC1 YES1 ACE2 TGM1 PALS1 FYB1 PACSIN2 | 3.99e-06 | 569 | 220 | 15 | 30639242 |
| Pubmed | TRIB3‒GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target. | 4.45e-06 | 18 | 220 | 4 | 34729304 | |
| Pubmed | MYH9 IGLV3-21 TUBB3 PIGR SF3A3 ALDH2 FN1 FAAP100 ARG1 TGM1 SF3B1 LMNB1 MYH14 SF3B6 CTSD ATP5F1A | 4.69e-06 | 652 | 220 | 16 | 31180492 | |
| Pubmed | DNAJB12 DLG5 ATP6V1E1 MYH9 MYH10 MYO1D RPN2 PFKL TUBB3 ANKRD28 ZNF598 SRSF1 PUF60 INPP5E MSH2 YES1 FAM83H PALS1 SF3B1 LMNB1 MYH14 EIF2S1 ATP5F1A | 4.91e-06 | 1247 | 220 | 23 | 27684187 | |
| Pubmed | Nonmuscle myosin II regulation of lung epithelial morphology. | 4.92e-06 | 6 | 220 | 3 | 22972683 | |
| Pubmed | 4.92e-06 | 6 | 220 | 3 | 30044719 | ||
| Pubmed | 4.92e-06 | 6 | 220 | 3 | 9158147 | ||
| Pubmed | 4.92e-06 | 6 | 220 | 3 | 15034141 | ||
| Pubmed | 4.92e-06 | 6 | 220 | 3 | 25926623 | ||
| Pubmed | 5.60e-06 | 70 | 220 | 6 | 20301607 | ||
| Pubmed | 6.24e-06 | 257 | 220 | 10 | 16335952 | ||
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 7.34e-06 | 156 | 220 | 8 | 30409884 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 7.82e-06 | 208 | 220 | 9 | 33230847 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | MYH9 MYH10 SF3A3 DMBT1 SRSF1 PUF60 PAF1 ARG1 SF3B1 LMNB1 EIF2S1 SF3B6 ZFHX3 CDK11B ATP5F1A | 8.29e-06 | 605 | 220 | 15 | 28977666 |
| Pubmed | Nonmuscle myosin II isoform and domain specificity during early mouse development. | 8.58e-06 | 7 | 220 | 3 | 20679233 | |
| Pubmed | DNAJB12 DLG5 ATP6V0A1 RPN2 TTC3 ANKRD28 ALDH2 ALDH9A1 CLUH NENF PDPR FLVCR1 MINK1 ZDHHC17 PAF1 YES1 SF3B1 LMNB1 EIF2S1 MAP4K5 SF3B6 MRPL48 PRKAR1B ROBO1 PACSIN2 | 9.23e-06 | 1487 | 220 | 25 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJB12 MYH10 URI1 VPS45 SPTB ADGRG1 PFKL PDE10A TTC3 GRHL2 BTG2 PTPRG ABCC8 KLHL23 FLVCR1 MINK1 MYRIP H6PD TECTA TSEN2 PWWP2B MYH14 KIAA1217 PRKAR1B ZFHX3 | 9.45e-06 | 1489 | 220 | 25 | 28611215 |
| Pubmed | 9.62e-06 | 45 | 220 | 5 | 22114352 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 1.02e-05 | 272 | 220 | 10 | 25315684 | |
| Pubmed | CHDH SPTB LRRK2 TTC3 HEPH FAT1 FBXO10 ARIH2 ANKRD28 FGFR2 MARVELD3 ITGA11 PUF60 GJC1 FAAP100 TSEN2 FAM83H FARS2 MAP4K5 GATAD1 ARHGAP45 PACSIN2 | 1.06e-05 | 1215 | 220 | 22 | 15146197 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DLG5 MYH9 MYH10 MYH11 PFKL DMBT1 SRSF1 RPS6KA4 PUF60 ARG1 TGM1 METTL13 SF3B1 LMNB1 MYH14 EIF2S1 CDK11B NEXN ATP5F1A | 1.11e-05 | 949 | 220 | 19 | 36574265 |
| Pubmed | ATP6V1E1 MYH9 MYH10 ATP6V0A1 SPTB PFKL PDE10A TUBB3 SV2A PACSIN1 LMNB1 ATP5F1A | 1.13e-05 | 403 | 220 | 12 | 30562941 | |
| Pubmed | MYH9 MYH10 MYH11 ZNF598 WRN MSH2 ARG1 SF3B1 CELF1 EIF2S1 MYO1F | 1.23e-05 | 340 | 220 | 11 | 24332808 | |
| Pubmed | 1.26e-05 | 23 | 220 | 4 | 18971422 | ||
| Pubmed | ATP6V1E1 MYH9 MYH10 MYH11 ATP6V0A1 PFKL TUBB3 SV2A SRSF1 PACSIN1 MYH14 CTSD ATP5F1A PACSIN2 | 1.30e-05 | 552 | 220 | 14 | 36293380 | |
| Pubmed | 1.33e-05 | 122 | 220 | 7 | 29530978 | ||
| Pubmed | Substrate specificity and activity regulation of protein kinase MELK. | 1.37e-05 | 8 | 220 | 3 | 16216881 | |
| Pubmed | Convergence and extrusion are required for normal fusion of the mammalian secondary palate. | 1.37e-05 | 8 | 220 | 3 | 25848986 | |
| Pubmed | Loss of cell adhesion causes hydrocephalus in nonmuscle myosin II-B-ablated and mutated mice. | 1.37e-05 | 8 | 220 | 3 | 17429076 | |
| Pubmed | 1.37e-05 | 8 | 220 | 3 | 33424621 | ||
| Pubmed | Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane. | 1.37e-05 | 8 | 220 | 3 | 21165971 | |
| Pubmed | 1.37e-05 | 8 | 220 | 3 | 15509736 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH9 MYH10 ATP6V0A1 MYO1D RPN2 PFKL TTC3 KLHL23 SF3A3 ALDH2 DNAH5 CLUH SRSF1 PUF60 MSH2 METTL13 SF3B1 LMNB1 MYH14 EIF2S1 RBPJ HARS1 CTSD ATP5F1A | 1.37e-05 | 1425 | 220 | 24 | 30948266 |
| Pubmed | MYH9 MYH10 MYH11 PACSIN1 MAP4K3 CEP290 ZDHHC17 MADD SF3B1 MAP4K5 PRKAR1B ROBO1 PACSIN2 | 1.52e-05 | 486 | 220 | 13 | 20936779 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | F13A1 ACSM3 SLC23A2 ARHGAP21 EXOSC4 NENF IGSF3 NEMP1 MAP4K3 MADD FAM83H PALS1 MRPL48 ROBO1 ALG3 PACSIN2 | 1.57e-05 | 719 | 220 | 16 | 35337019 |
| Pubmed | SIK2 orchestrates actin-dependent host response upon Salmonella infection. | 1.63e-05 | 50 | 220 | 5 | 33947818 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 1.68e-05 | 288 | 220 | 10 | 31501420 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH9 UAP1 MYH10 MYH11 RPN2 VPS33A RYR1 TUBB3 PUF60 GNPNAT1 XPNPEP1 LMNB1 MYH14 ZFHX3 HARS1 CTSD ATP5F1A | 1.72e-05 | 807 | 220 | 17 | 30575818 |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | ATP6V0A1 RPN2 SF3A3 SRSF1 PUF60 PAF1 SF3B1 EIF2S1 MRPL48 CDK11B ATP5F1A ALDH7A1 | 1.79e-05 | 422 | 220 | 12 | 27342126 |
| Pubmed | 2.04e-05 | 9 | 220 | 3 | 21081122 | ||
| Pubmed | 2.12e-05 | 131 | 220 | 7 | 28634551 | ||
| Pubmed | ATP6V1E1 MYH9 MYH10 PFKL RRAGC TUBB3 SRSF1 GJC1 MSH2 PAF1 YES1 SF3B1 LMNB1 EIF2S1 SF3B6 | 2.29e-05 | 660 | 220 | 15 | 32780723 | |
| Pubmed | MYH9 NAGA LRRK2 PFKL CSMD3 TUBB3 CPNE9 SRSF1 TECTA SF3B1 CELSR3 KIAA1217 ATP5F1A | 2.67e-05 | 513 | 220 | 13 | 25798074 | |
| Pubmed | Structural basis of branch site recognition by the human spliceosome. | 2.90e-05 | 10 | 220 | 3 | 34822310 | |
| Pubmed | A novel U2 and U11/U12 snRNP protein that associates with the pre-mRNA branch site. | 2.90e-05 | 10 | 220 | 3 | 11500380 | |
| Pubmed | A point mutation in Myh10 causes major defects in heart development and body wall closure. | 2.90e-05 | 10 | 220 | 3 | 24825879 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ATP6V1E1 MYH9 MYH10 MYH11 RPN2 VPS33A SF3A3 MSH2 PAF1 HARS2 SF3B1 MYH14 EIF2S1 KIAA1217 PRKAR1B HARS1 ATP5F1A | 3.15e-05 | 847 | 220 | 17 | 35235311 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | PTPRF PTPRG SLC23A2 IGSF3 FLVCR1 MINK1 GJC1 YES1 MAP4K5 ROBO1 PACSIN2 | 3.17e-05 | 377 | 220 | 11 | 38117590 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DLG5 MYH10 MYO1D VPS45 AGO3 MTMR2 ANKRD28 ZNF598 DNMBP ARHGAP21 MAP4K3 CEP290 YES1 FAM83H LMNB1 KIAA1217 ALDH7A1 | 3.44e-05 | 853 | 220 | 17 | 28718761 |
| Pubmed | ATP6V0A1 LRRK2 METAP1D PDE10A TTC3 GRHL2 MTMR2 SCNN1G ANKRD28 ENTPD7 CEP290 GNPNAT1 TMTC1 GATAD1 SEMA3E | 3.56e-05 | 686 | 220 | 15 | 29987050 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 3.95e-05 | 197 | 220 | 8 | 22365833 | |
| Pubmed | 3.97e-05 | 11 | 220 | 3 | 31776257 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 19549836 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 22173703 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 16432215 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 10200315 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 26181369 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 23966470 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 30455249 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 17826360 | ||
| Pubmed | Using thermal scanning assays to test protein-protein interactions of inner-ear cadherins. | 3.98e-05 | 2 | 220 | 2 | 29261728 | |
| Pubmed | FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness. | 3.98e-05 | 2 | 220 | 2 | 27236187 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 33188738 | ||
| Interaction | YWHAZ interactions | DLG5 MYH9 UAP1 MYH10 MYH11 ESR1 LRRK2 PFKL KCNK3 ANKRD28 ALDH2 ALDH9A1 ZNF598 DNMBP ARHGAP21 REM1 HDAC6 FN1 PUF60 INPP5E MINK1 MADD FAM83H ARG1 ACE2 VPS13D SF3B1 GAN CDK11B HARS1 CTSD CRBN ATP5F1A GABBR1 | 2.30e-06 | 1319 | 219 | 34 | int:YWHAZ |
| Interaction | HSPB1 interactions | UAP1 ESR1 RNF113A LRRK2 RBM48 TTC3 F13A1 SF3A3 HDAC6 FN1 MSH2 PAF1 YES1 ACE2 TGM1 EIF2S1 PDIK1L KIAA1217 RBPJ SMN1 NEXN ATP5F1A | 1.01e-05 | 708 | 219 | 22 | int:HSPB1 |
| Interaction | PRMT5 interactions | MYH9 MYH10 ESR1 RNF113A KDM3B AGO3 ARIH2 SF3A3 ZNF598 FN1 MAU2 ZDHHC17 ACE2 TRIB3 EIF2S1 GAN SMN1 | 1.66e-05 | 471 | 219 | 17 | int:PRMT5 |
| Interaction | USP10 interactions | ESR1 RNF113A PHLPP1 ANKRD28 CLUH HDAC6 PUF60 MAP4K3 MSH2 ACE2 SF3B1 LMNB1 CELF1 | 1.84e-05 | 290 | 219 | 13 | int:USP10 |
| Interaction | LGALS8 interactions | 2.14e-05 | 174 | 219 | 10 | int:LGALS8 | |
| Interaction | FLNA interactions | TDRD15 MYH9 UAP1 MYH11 ESR1 RNF113A AGO3 PIGR PHLPP1 ZNF598 CLUH ARHGAP21 HDAC6 FN1 GRIK3 MAU2 GRM5 ACE2 CTSD NEXN | 2.87e-05 | 648 | 219 | 20 | int:FLNA |
| Interaction | TUBA1B interactions | MYH9 ESR1 RNF113A TUBB3 PTPRF PIGR ARIH2 MTMR2 ZNF598 HDAC6 FN1 MINK1 CEP290 MAU2 ACE2 SF3B1 GAN | 3.37e-05 | 498 | 219 | 17 | int:TUBA1B |
| Interaction | RAI14 interactions | CFH MYH9 RPN2 ESR1 LRRK2 TTC3 PHLPP1 PACSIN1 ACE2 PRKAR1B PACSIN2 | 3.58e-05 | 224 | 219 | 11 | int:RAI14 |
| Interaction | EEF1G interactions | ESR1 RNF113A PFKL TUBB3 PTPRF ARIH2 ANKRD28 ZNF598 HDAC6 FN1 ABCC9 MSH2 ZDHHC17 ACE2 TRIB3 HARS1 | 4.98e-05 | 463 | 219 | 16 | int:EEF1G |
| Interaction | DDX39B interactions | MYH9 MYH10 RPN2 TUBB3 PIGR SF3A3 FGFR2 HDAC6 FN1 ARG1 ACE2 TGM1 SF3B1 LMNB1 MYH14 GAN CTSD ATP5F1A | 5.44e-05 | 570 | 219 | 18 | int:DDX39B |
| Interaction | HMG20B interactions | 5.70e-05 | 122 | 219 | 8 | int:HMG20B | |
| Interaction | RAB35 interactions | DLG5 MYO1D VPS45 PTPRF PTPRG ARHGAP21 IGSF3 HDAC6 FN1 FLVCR1 MINK1 YES1 ACE2 PALS1 LMNB1 MAP4K5 ROBO1 PACSIN2 | 5.82e-05 | 573 | 219 | 18 | int:RAB35 |
| Interaction | U2AF1 interactions | RNF113A SUV39H1 SF3A3 CLUH SRSF1 FN1 MINK1 EFHC2 ACE2 SF3B1 SF3B6 | 6.44e-05 | 239 | 219 | 11 | int:U2AF1 |
| Interaction | MSN interactions | MYH9 LRRK2 F13A1 TUBB3 PHLPP1 ARHGAP21 HDAC6 FN1 GSS CDK11B CFAP44 CTSD ATP5F1A | 6.98e-05 | 330 | 219 | 13 | int:MSN |
| Interaction | LGALS1 interactions | CHL1 MYH9 ATP6V0A1 RNF113A PTPRG PIGR SDK1 CLUH IGSF3 HDAC6 FN1 ACE2 SMN1 | 7.42e-05 | 332 | 219 | 13 | int:LGALS1 |
| Interaction | TRIOBP interactions | 7.58e-05 | 127 | 219 | 8 | int:TRIOBP | |
| Interaction | PRKDC interactions | ESR1 RNF113A LRRK2 TTC3 PHLPP1 ANKRD28 FGFR2 ZNF598 SRSF1 HDAC6 FN1 PUF60 WRN MAU2 ACE2 PWWP2B SF3B1 EIF2S1 KIAA1217 SF3B6 | 7.58e-05 | 695 | 219 | 20 | int:PRKDC |
| Interaction | PLEC interactions | MYH9 ESR1 RNF113A LRRK2 PHLPP1 DNAH5 MXRA5 HDAC6 FN1 ACE2 LMNB1 PRKAR1B GAN PAPPA CTSD | 7.74e-05 | 430 | 219 | 15 | int:PLEC |
| Interaction | MYH9 interactions | MYH9 MYH10 MYH11 ESR1 RNF113A LRRK2 KDM3B AGO3 PHLPP1 ZNF598 DNAH5 ARHGAP21 HDAC6 FN1 YES1 ACE2 TRIB3 MYH14 NEXN ATP5F1A MYBPC3 | 7.93e-05 | 754 | 219 | 21 | int:MYH9 |
| Interaction | KCNA3 interactions | CHL1 DNAJB12 DLG5 MYH9 MYO1D RPN2 LRRK2 RYR1 TUBB3 DNAH5 ARHGAP21 HDAC6 PUF60 MYH7B MINK1 MSH2 XPNPEP1 LMNB1 MAP4K5 ROBO1 ATP5F1A HCLS1 PACSIN2 | 8.03e-05 | 871 | 219 | 23 | int:KCNA3 |
| Interaction | NRAS interactions | RPN2 VPS45 ESR1 VPS33A HEPH RRAGC TUBB3 FAT1 PTPRG SLC23A2 MAP4K3 FLVCR1 MINK1 GJC1 YES1 ATL1 TDRD7 ROBO1 FYB1 PACSIN2 | 8.20e-05 | 699 | 219 | 20 | int:NRAS |
| Interaction | ENO1 interactions | MYH9 MYH10 MYH11 ATP6V0A1 LRRK2 ZNF598 NENF PDPR HDAC6 FN1 MAP4K3 XPNPEP1 PAF1 MORC4 TSEN2 TDRD7 ACE2 MYH14 FARS2 GATAD1 | 8.52e-05 | 701 | 219 | 20 | int:ENO1 |
| Interaction | PABIR3 interactions | 1.01e-04 | 9 | 219 | 3 | int:PABIR3 | |
| Interaction | WDR18 interactions | 1.05e-04 | 133 | 219 | 8 | int:WDR18 | |
| Interaction | GAN interactions | DLG5 SPTB TUBB3 CLUH IGSF3 MXRA5 MAP4K3 CELSR3 MYH14 GAN CFAP44 | 1.07e-04 | 253 | 219 | 11 | int:GAN |
| Interaction | KCTD13 interactions | ATP6V1E1 MYH9 MYH10 MYH11 ATP6V0A1 MYO1D VPS45 SPTB PFKL TUBB3 NEGR1 SV2A MTMR2 ALDH2 ARHGAP21 SRSF1 FN1 PACSIN1 MAP4K3 MINK1 GRM5 MADD TGM1 THBS4 SF3B1 MYH14 EIF2S1 KIAA1217 MRPL48 ATP5F1A ALDH7A1 | 1.13e-04 | 1394 | 219 | 31 | int:KCTD13 |
| Interaction | SNRPD1 interactions | ESR1 ARIH2 SF3A3 SRSF1 FN1 PUF60 MAP4K3 ACE2 SF3B1 LMNB1 SF3B6 SMN1 CRBN | 1.16e-04 | 347 | 219 | 13 | int:SNRPD1 |
| Interaction | PFKL interactions | ESR1 RNF113A VPS33A PFKL HDAC6 FN1 MSH2 ACE2 PRKAR1B ATP5F1A | 1.22e-04 | 214 | 219 | 10 | int:PFKL |
| Interaction | CHMP4B interactions | ATP6V1E1 MYH9 MYH10 MYH11 ATP6V0A1 ESR1 SPTB KDM3B ARHGAP21 SRSF1 PUF60 FAM83H SF3B1 LMNB1 MYH14 RBPJ MYO1F SMN1 NEXN ATP5F1A | 1.39e-04 | 727 | 219 | 20 | int:CHMP4B |
| Interaction | IFITM1 interactions | ATP6V1E1 MYH9 MYH10 MYO1D VPS45 SPTB VPS33A PFKL RRAGC PTPRF FGFR2 YES1 EIF2S1 | 1.45e-04 | 355 | 219 | 13 | int:IFITM1 |
| Interaction | WDFY4 interactions | 1.57e-04 | 141 | 219 | 8 | int:WDFY4 | |
| Interaction | HNRNPU interactions | MYH9 MYH10 RNF113A PFKL AGO3 ARIH2 SF3A3 ARHGAP21 EXOSC4 SRSF1 HDAC6 FN1 CEP290 MSH2 MAU2 ACE2 SF3B1 LMNB1 CELF1 MAP4K5 SF3B6 MRPL48 GAN CRBN ATP5F1A | 1.59e-04 | 1035 | 219 | 25 | int:HNRNPU |
| Interaction | RHOH interactions | DLG5 ATP6V0A1 MICOS13 VPS45 TENM2 PTPRF PTPRG IGSF3 FLVCR1 MINK1 XPNPEP1 YES1 VPS13D LMNB1 ROBO1 PACSIN2 | 1.60e-04 | 512 | 219 | 16 | int:RHOH |
| Interaction | C11orf52 interactions | DLG5 MYO1D PTPRF PTPRG ARHGAP21 IGSF3 FLVCR1 MINK1 YES1 MAP4K5 ROBO1 PACSIN2 | 1.61e-04 | 311 | 219 | 12 | int:C11orf52 |
| Interaction | LOXL2 interactions | MYH9 MYH10 MYH11 MYO1D PFKL ALDH2 ALDH1A3 MAP4K3 ARG1 TGM1 LMNB1 MYH14 CTSD ATP5F1A | 1.67e-04 | 410 | 219 | 14 | int:LOXL2 |
| Interaction | WIPF1 interactions | 1.69e-04 | 48 | 219 | 5 | int:WIPF1 | |
| Interaction | SNRPB interactions | LRRK2 ARIH2 SF3A3 SRSF1 HDAC6 FN1 PUF60 MINK1 CEP290 PAF1 YES1 ACE2 SF3B1 SF3B6 SMN1 CRBN | 1.79e-04 | 517 | 219 | 16 | int:SNRPB |
| Interaction | SPDL1 interactions | MYH9 MYH10 MYH11 CDH23 TUBB3 PHLPP1 CPNE9 VPS13D SF3B1 MYH14 EIF2S1 HARS1 | 1.81e-04 | 315 | 219 | 12 | int:SPDL1 |
| Interaction | SREK1 interactions | 1.82e-04 | 183 | 219 | 9 | int:SREK1 | |
| Interaction | ARPC3 interactions | 1.82e-04 | 183 | 219 | 9 | int:ARPC3 | |
| Interaction | GAPDH interactions | MYH9 ESR1 RNF113A KDM3B PFKL RYR1 AGO3 PTPRF ZNF598 ARHGAP21 HDAC6 FN1 PUF60 MYH7B CEP290 MAU2 ACE2 SMN1 ZFHX3 | 1.88e-04 | 686 | 219 | 19 | int:GAPDH |
| Interaction | SNW1 interactions | MYH9 ESR1 PFKL TUBB3 SF3A3 PHLPP1 SRSF1 PUF60 MSH2 MAU2 ZDHHC17 ACE2 METTL13 SF3B1 LMNB1 SF3B6 RBPJ PRKAR1B SMN1 HARS1 | 1.99e-04 | 747 | 219 | 20 | int:SNW1 |
| Interaction | SRSF3 interactions | ATP6V1E1 ATP6V0A1 ESR1 RNF113A ARIH2 MTMR2 SF3A3 CLUH SRSF1 HDAC6 FN1 ACE2 SF3B1 MRPL48 SMN1 CRBN | 1.99e-04 | 522 | 219 | 16 | int:SRSF3 |
| Interaction | RND3 interactions | DLG5 PTPRF PTPRG ARHGAP21 PLXNB1 FLVCR1 YES1 KIAA1217 RBPJ ROBO1 PACSIN2 | 2.08e-04 | 273 | 219 | 11 | int:RND3 |
| Interaction | PUF60 interactions | CFH RNF113A LRRK2 SF3A3 SRSF1 HDAC6 FN1 PUF60 XPNPEP1 ACE2 SF3B1 SF3B6 CRBN | 2.11e-04 | 369 | 219 | 13 | int:PUF60 |
| Interaction | MYH14 interactions | 2.32e-04 | 189 | 219 | 9 | int:MYH14 | |
| Interaction | FUS interactions | MYH10 RPN2 ESR1 RNF113A PFKL SUV39H1 ARIH2 SF3A3 CLUH SRSF1 HDAC6 FN1 PAF1 ACE2 HARS2 SF3B1 CELF1 SMN1 CRBN ATP5F1A | 2.37e-04 | 757 | 219 | 20 | int:FUS |
| Interaction | RAC1 interactions | DLG5 MYH9 RPN2 VPS45 ESR1 LRRK2 SOWAHC TUBB3 FAT1 AGO3 PTPRF PTPRG DNMBP ARHGAP21 PLXNB1 IGSF3 HDAC6 FN1 FLVCR1 MINK1 YES1 LMNB1 MAP4K5 ROBO1 PACSIN2 | 2.39e-04 | 1063 | 219 | 25 | int:RAC1 |
| Interaction | YWHAE interactions | DLG5 UAP1 MYH10 MYH11 ESR1 LRRK2 TTC3 KCNK3 MTMR2 ALDH2 ZNF598 DNMBP ARHGAP21 REM1 SRSF1 HDAC6 FN1 INPP5E MINK1 FAM83H GSS ACE2 SF3B1 LMNB1 CDK11B ARHGAP45 ATP5F1A ALDH7A1 | 2.40e-04 | 1256 | 219 | 28 | int:YWHAE |
| Interaction | HSP90AA1 interactions | MYH9 URI1 ESR1 LRRK2 STK35 ITIH1 FBXO10 AGO3 PTPRF SV2A KLHL23 CFAP70 ZNF598 RPS6KA4 HDAC6 FN1 MINK1 YES1 MAP3K6 CDK10 FAM83H ACE2 EIF2S1 PDIK1L GAN CDK11B CRBN ATP5F1A | 2.63e-04 | 1263 | 219 | 28 | int:HSP90AA1 |
| GeneFamily | Myosin heavy chains | 1.56e-07 | 15 | 163 | 5 | 1098 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | CHL1 PTPRF NEGR1 FGFR2 SDK1 MXRA5 ROBO1 IL1R1 NEXN LRIT1 MYBPC3 | 2.37e-07 | 161 | 163 | 11 | 593 |
| GeneFamily | Fibronectin type III domain containing | 1.49e-05 | 160 | 163 | 9 | 555 | |
| GeneFamily | Aldehyde dehydrogenases | 2.22e-05 | 19 | 163 | 4 | 398 | |
| GeneFamily | Transglutaminases | 5.81e-05 | 9 | 163 | 3 | 773 | |
| GeneFamily | Tudor domain containing | 3.33e-04 | 37 | 163 | 4 | 780 | |
| GeneFamily | Cadherin related | 4.46e-04 | 17 | 163 | 3 | 24 | |
| GeneFamily | Actins|Deafness associated genes | 5.59e-04 | 113 | 163 | 6 | 1152 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 6.27e-04 | 19 | 163 | 3 | 132 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 7.94e-04 | 5 | 163 | 2 | 655 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 1.12e-03 | 23 | 163 | 3 | 1288 | |
| GeneFamily | Acyl-CoA synthetase family | 1.61e-03 | 26 | 163 | 3 | 40 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.73e-03 | 57 | 163 | 4 | 1179 | |
| GeneFamily | Myosins, class I | 2.18e-03 | 8 | 163 | 2 | 1097 | |
| GeneFamily | ATP binding cassette subfamily C | 5.90e-03 | 13 | 163 | 2 | 807 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.03e-03 | 181 | 163 | 6 | 694 | |
| GeneFamily | Kelch like|BTB domain containing | 6.38e-03 | 42 | 163 | 3 | 617 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | CHL1 DNAJB12 DLG5 CHDH ZNF202 RRAGC AGO3 PTPRF ARIH2 MTMR2 SF3A3 ANKRD28 EXOC6 MYRIP XPNPEP1 H6PD VPS13D MRPL48 RBPJ CRBN EPHA10 | 4.98e-06 | 807 | 220 | 21 | M14594 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CHL1 LRRK2 TTC3 CSMD3 TENM2 RNF157 TUBB3 KCNC1 NEGR1 SV2A TMEM255A IGSF3 GRIK3 GRM5 ATL1 EFHC2 CELSR3 CELF1 PDIK1L PRKAR1B ROBO1 PAPPA ZFHX3 SEMA3E | 2.15e-05 | 1106 | 220 | 24 | M39071 |
| Coexpression | FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL | HGD MYH10 ESR1 ACSL1 BTG2 PIK3CB FGFR2 ALDH1A3 ANXA9 ZDHHC17 MORC4 ACE2 | 2.28e-05 | 327 | 220 | 12 | M4008 |
| Coexpression | PILON_KLF1_TARGETS_UP | EXD1 ITIH1 RNF157 PTPRF ABCC8 FGFR2 SLC23A2 IGSF3 EXOC6 FN1 MYH7B ABCC9 HARS2 HARS1 EPB42 | 2.53e-05 | 503 | 220 | 15 | M2226 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | CFH ATP6V1E1 URI1 RPN2 KDM3B ADGRG1 ACSL1 ACSM3 PIK3CB ARIH2 EID1 MTMR2 SF3A3 ALDH9A1 SRSF1 HDAC6 WRN MSH2 XPNPEP1 YES1 GSS FARS2 MAP4K5 RBPJ ALG3 CRBN PACSIN2 | 4.97e-05 | 1399 | 220 | 27 | M535 |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN | 4.97e-05 | 199 | 220 | 9 | M3912 | |
| Coexpression | GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP | 4.97e-05 | 199 | 220 | 9 | M6395 | |
| Coexpression | GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN | 5.17e-05 | 200 | 220 | 9 | M9773 | |
| Coexpression | ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN | 5.73e-05 | 116 | 220 | 7 | M2222 | |
| Coexpression | PILON_KLF1_TARGETS_UP | EXD1 ITIH1 RNF157 PTPRF ABCC8 FGFR2 SLC23A2 IGSF3 EXOC6 FN1 MYH7B ABCC9 HARS2 HARS1 EPB42 | 5.79e-05 | 541 | 220 | 15 | MM1061 |
| Coexpression | IBRAHIM_NRF1_UP | UAP1 RPN2 ACSL1 TUBB3 SF3A3 ALDH2 SRSF1 GNPNAT1 PWWP2B CELF1 MAP4K5 GAN HARS1 | 6.06e-05 | 420 | 220 | 13 | M42509 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | CHL1 SLC36A1 RBM48 GRHL2 TENM2 BTG2 PTPRF PIK3CB PHLPP1 FGFR2 MARVELD3 ANXA9 PLXNB1 MYRIP YES1 FAM83H ARG1 EFHC2 TGM1 SLC15A2 FARS2 MAP4K5 ROBO1 SEMA3E | 3.19e-06 | 800 | 220 | 24 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | CHL1 MYH11 KLHL28 VPS33A TENM2 TUBB3 PTPRG DNMBP TMEM255A IGSF3 SRSF1 WRN ABCC9 YES1 ARG1 LMNB1 CELF1 SLC15A2 RBPJ PRKAR1B ROBO1 NEXN HCCS SEMA3E | 3.63e-06 | 806 | 220 | 24 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#1_top-relative-expression-ranked_1000 | GRHL2 PTPRF PIK3CB FGFR2 VSTM5 ANXA9 CEP290 FAM83H ARG1 TGM1 SLC15A2 SEMA3E | 1.29e-05 | 251 | 220 | 12 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#1_top-relative-expression-ranked_1000 | GRHL2 PTPRF PHLPP1 MARVELD3 ANXA9 FAM83H ARG1 TGM1 SLC15A2 SEMA3E | 2.78e-05 | 188 | 220 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#5_top-relative-expression-ranked_1000 | CHL1 GRHL2 SCNN1G PHLPP1 MARVELD3 ANXA9 FAM83H SLC15A2 SEMA3E | 6.35e-05 | 167 | 220 | 9 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_200 | 6.65e-05 | 168 | 220 | 9 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_500 | CHL1 GRHL2 TENM2 BTG2 PIK3CB MARVELD3 YES1 FAM83H ARG1 TGM1 SLC15A2 FARS2 ROBO1 SEMA3E | 8.11e-05 | 401 | 220 | 14 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | CFH HGD ATP6V1E1 MYH11 SLC36A1 MYO1D NAGA LRRK2 ADGRG1 ACSL1 GK ACSM3 SV2A SCNN1G ALDH9A1 EXOC6 CUBN ACE2 SLC15A2 CTSD ALDH7A1 | 9.22e-05 | 799 | 220 | 21 | gudmap_kidney_adult_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | CHL1 KLHL28 VPS33A TTC3 CSMD3 TENM2 RNF157 TUBB3 PTPRG NEGR1 ALDH1A3 SRSF1 WRN MYRIP LMNB1 CELF1 SLC15A2 MAP4K5 RBPJ ROBO1 SEMA3E | 1.28e-04 | 818 | 220 | 21 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | CHL1 MYH9 UAP1 KLHL28 VPS33A TENM2 TUBB3 PTPRF PTPRG NEGR1 DNMBP IGSF3 SRSF1 MYRIP YES1 TMTC1 CELSR3 LMNB1 SLC15A2 PRKAR1B ZFHX3 | 1.28e-04 | 818 | 220 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#2_top-relative-expression-ranked_500 | 1.59e-04 | 148 | 220 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#3_top-relative-expression-ranked_500 | 1.83e-04 | 80 | 220 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | CHL1 KLHL28 GRHL2 ACSM3 PTPRF PIK3CB SCNN1G FGFR2 MARVELD3 VSTM5 ANXA9 EXOC6 CEP290 FAM83H ARG1 TGM1 PWWP2B SLC15A2 MYH14 SEMA3E | 1.89e-04 | 780 | 220 | 20 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | CFH HGD MYH11 MYO1D NAGA LRRK2 GRHL2 ACSL1 GK BTG2 SCNN1G TMEM255A FN1 ABCC9 CUBN ACE2 THBS4 SLC15A2 ZFHX3 IL1R1 NEXN ALDH7A1 | 1.91e-04 | 905 | 220 | 22 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | CFH STOX1 PDE10A PIGR SCNN1G FGFR2 ALDH1A3 DNAH5 SDK1 SLC15A2 KIAA1217 | 2.01e-09 | 182 | 221 | 11 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CHL1 CFH PDE10A PIGR SCNN1G FGFR2 ALDH1A3 SDK1 SLC15A2 KIAA1217 SEMA3E | 5.39e-09 | 200 | 221 | 11 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CHL1 CFH PDE10A PIGR SCNN1G FGFR2 ALDH1A3 SDK1 SLC15A2 KIAA1217 | 2.10e-08 | 177 | 221 | 10 | 0f210cfb61b873c5fd77dc17eadf4d017306500e |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CHL1 CFH PDE10A PIGR SCNN1G FGFR2 ALDH1A3 SDK1 SLC15A2 KIAA1217 | 2.10e-08 | 177 | 221 | 10 | 779ba86f53650772755b52460be03f18bb204e55 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CFH ITGA11 ABCC9 GRIK3 TECTA KIAA1217 ZFHX3 CDH9 HCLS1 SEMA3E | 2.46e-08 | 180 | 221 | 10 | e8841ef1239f9ee73ac4f4e11faca0742694f368 |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.10e-08 | 190 | 221 | 10 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-08 | 191 | 221 | 10 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-08 | 191 | 221 | 10 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CFH MYH11 ESR1 NEGR1 ITGA11 ABCC9 TMTC1 KIAA1217 ROBO1 ADAMTSL2 | 4.53e-08 | 192 | 221 | 10 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | CHL1 GRHL2 FAT1 PIGR FGFR2 ALDH1A3 DNAH5 SDK1 MYH14 KIAA1217 | 4.53e-08 | 192 | 221 | 10 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab |
| ToppCell | LA|World / Chamber and Cluster_Paper | 4.75e-08 | 193 | 221 | 10 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CFH ESR1 HEPH NEGR1 ITGA11 ABCC9 TMTC1 KIAA1217 NEXN ADAMTSL2 | 4.99e-08 | 194 | 221 | 10 | 81713e0409e8be695ba5dfdc67a997b33435dd9e |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 4.99e-08 | 194 | 221 | 10 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CFH ESR1 HEPH NEGR1 ITGA11 ABCC9 TMTC1 KIAA1217 NEXN ADAMTSL2 | 4.99e-08 | 194 | 221 | 10 | 627cffe2d448e74fc5df92e74e5b922a73304137 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CFH ESR1 HEPH NEGR1 ITGA11 ABCC9 TMTC1 KIAA1217 NEXN ADAMTSL2 | 4.99e-08 | 194 | 221 | 10 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | ESR1 NEGR1 ALDH1A3 SDK1 ITGA11 ABCC9 TMTC1 ROBO1 PAPPA IL1R1 | 5.24e-08 | 195 | 221 | 10 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.05e-08 | 198 | 221 | 10 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.34e-08 | 199 | 221 | 10 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.34e-08 | 199 | 221 | 10 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.65e-08 | 200 | 221 | 10 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.18e-07 | 161 | 221 | 9 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.18e-07 | 161 | 221 | 9 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-07 | 162 | 221 | 9 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-07 | 166 | 221 | 9 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | Ionocyte-iono-2|World / Class top | 2.18e-07 | 173 | 221 | 9 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.18e-07 | 173 | 221 | 9 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.35e-07 | 182 | 221 | 9 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.35e-07 | 182 | 221 | 9 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.35e-07 | 182 | 221 | 9 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-07 | 184 | 221 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-07 | 184 | 221 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-07 | 184 | 221 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.84e-07 | 185 | 221 | 9 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 4.02e-07 | 186 | 221 | 9 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.21e-07 | 187 | 221 | 9 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.21e-07 | 187 | 221 | 9 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.21e-07 | 187 | 221 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-07 | 187 | 221 | 9 | fe9fc21192ede2eea61f419d20ccda254569d0a6 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.21e-07 | 187 | 221 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-07 | 189 | 221 | 9 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-07 | 189 | 221 | 9 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-07 | 190 | 221 | 9 | bfbdf16d488359d7935a419c4c1823288f39c183 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 4.81e-07 | 190 | 221 | 9 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-07 | 190 | 221 | 9 | eb1f8bb4d903b08e50c2dc173b06c0c79d8e316e | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 4.81e-07 | 190 | 221 | 9 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | IPF-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 4.81e-07 | 190 | 221 | 9 | c29dabf0826663b9d6df51a7af9b76592090e44c | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.84e-07 | 139 | 221 | 8 | 2fb51abb3ce88c21726c026d6365b2582e2e79f6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-07 | 191 | 221 | 9 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-07 | 191 | 221 | 9 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | IPF-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 5.03e-07 | 191 | 221 | 9 | 267e1192aaec468c1a59eb24848b37e0e18cbc44 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.25e-07 | 192 | 221 | 9 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.25e-07 | 192 | 221 | 9 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.49e-07 | 193 | 221 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 5.49e-07 | 193 | 221 | 9 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-07 | 194 | 221 | 9 | 96f16bcd393a0d3f8df479b172b5360ae5a1e663 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 5.73e-07 | 194 | 221 | 9 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 5.73e-07 | 194 | 221 | 9 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-07 | 194 | 221 | 9 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-07 | 194 | 221 | 9 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.73e-07 | 194 | 221 | 9 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-07 | 194 | 221 | 9 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-07 | 194 | 221 | 9 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-07 | 195 | 221 | 9 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-07 | 195 | 221 | 9 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-07 | 195 | 221 | 9 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-07 | 195 | 221 | 9 | ce8215d503cad3a9bc7d5d2be4adb57408015593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-07 | 196 | 221 | 9 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-07 | 196 | 221 | 9 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.24e-07 | 196 | 221 | 9 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.24e-07 | 196 | 221 | 9 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | critical-Epithelial-Secretory|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.24e-07 | 196 | 221 | 9 | 7da687eb983a54c28ee990424cc52e01caf5f4aa | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.24e-07 | 196 | 221 | 9 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-07 | 144 | 221 | 8 | 57d2846ec26d4490ec11c171af447b17a729437e | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.33e-07 | 144 | 221 | 8 | 7c471e332f87d60f4dbed01f3e66bf39995218d0 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.51e-07 | 197 | 221 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 6.51e-07 | 197 | 221 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-07 | 198 | 221 | 9 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 6.79e-07 | 198 | 221 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.79e-07 | 198 | 221 | 9 | c9c96066c7fa897b583657f0b77ea093920ae9ba | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 6.79e-07 | 198 | 221 | 9 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.79e-07 | 198 | 221 | 9 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.09e-07 | 199 | 221 | 9 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.39e-07 | 200 | 221 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.54e-07 | 152 | 221 | 8 | d88d68a788a3256671ebbc06e104833f1f58f07d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.54e-07 | 152 | 221 | 8 | d5ba87b5d34e52cef8475befafea962d70fa8a1d | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.54e-07 | 152 | 221 | 8 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-06 | 157 | 221 | 8 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-06 | 161 | 221 | 8 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-06 | 161 | 221 | 8 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 166 | 221 | 8 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.11e-06 | 169 | 221 | 8 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 2.63e-06 | 174 | 221 | 8 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-06 | 175 | 221 | 8 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | Club_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.86e-06 | 176 | 221 | 8 | 88c4ed0ab4a4ede8cad21385d799b723b5786cd9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-06 | 178 | 221 | 8 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.24e-06 | 179 | 221 | 8 | b7a2429d07d7146b32b3552a5f2a2542105a71e0 | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 3.38e-06 | 180 | 221 | 8 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.52e-06 | 181 | 221 | 8 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-06 | 181 | 221 | 8 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 3.52e-06 | 181 | 221 | 8 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| Drug | 3-butynoate | 2.90e-07 | 7 | 220 | 4 | CID000137547 | |
| Drug | 3-butynal | 2.90e-07 | 7 | 220 | 4 | CID000142966 | |
| Drug | tamibarotene | MYH10 MYH11 SLC36A1 ATP6V0A1 ESR1 TTC3 TUBB3 FAT1 BTG2 PTPRF PIK3CB DMBT1 NEMP1 CDK10 TGM1 LMNB1 CELF1 GATAD1 CTSD FYB1 ARHGAP45 | 3.74e-07 | 596 | 220 | 21 | ctd:C061133 |
| Drug | betaine aldehyde | 5.58e-07 | 32 | 220 | 6 | CID000000249 | |
| Drug | C04554 | 5.76e-07 | 8 | 220 | 4 | CID000440384 | |
| Drug | CPD 30 | 1.03e-06 | 9 | 220 | 4 | CID000440850 | |
| Drug | 4-acetamidobutyrate | 1.03e-06 | 9 | 220 | 4 | CID000018189 | |
| Drug | isoproterenol | MYH9 MYH10 MYH11 URI1 MYO1D PDE10A RYR1 TUBB3 ACSM3 ABCC8 PCDH15 SCNN1G MYH7B MYRIP ABCC9 PAF1 ACE2 GUCY2C MYH14 ALDH7A1 MYBPC3 | 2.37e-06 | 669 | 220 | 21 | CID000003779 |
| Drug | ynoate | 2.65e-06 | 11 | 220 | 4 | CID000010110 | |
| Drug | Capsaicin [404-86-4]; Up 200; 13uM; HL60; HT_HG-U133A | MYH11 ESR1 KCNC1 ENTPD7 FN1 FKRP MAU2 TECTA MYH14 PAPPA FYB1 | 3.29e-06 | 195 | 220 | 11 | 3034_UP |
| Drug | Taylor D | 3.53e-06 | 4 | 220 | 3 | CID000394229 | |
| Drug | imidazole acetaldehyde | 3.95e-06 | 12 | 220 | 4 | CID000150841 | |
| Drug | phenylacetaldehyde | 5.81e-06 | 100 | 220 | 8 | CID000000998 | |
| Drug | indole-3-acetaldehyde | 6.60e-06 | 28 | 220 | 5 | CID000000800 | |
| Drug | formycin triphosphate | 9.52e-06 | 51 | 220 | 6 | CID000122274 | |
| Drug | clenbuterol | 1.02e-05 | 142 | 220 | 9 | CID000002783 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 1.07e-05 | 15 | 220 | 4 | CID000440673 | |
| Drug | perillic acid | 1.11e-05 | 31 | 220 | 5 | CID000001256 | |
| Drug | glycurone | 1.41e-05 | 16 | 220 | 4 | CID000003483 | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 1.47e-05 | 187 | 220 | 10 | 2669_DN | |
| Drug | trimethylaminobutyraldehyde | 1.83e-05 | 17 | 220 | 4 | CID000000133 | |
| Drug | propynal | 1.83e-05 | 17 | 220 | 4 | CID000012222 | |
| Drug | B0683 | 1.85e-05 | 117 | 220 | 8 | CID006398969 | |
| Drug | purealin | 2.02e-05 | 58 | 220 | 6 | CID006419303 | |
| Drug | pyrophosphate | MYH9 UAP1 MYH10 MYH11 MYO1D PFKL ACSL1 PIK3CB ALDH2 ENTPD7 FN1 MYH7B HARS2 TMTC1 GUCY2C MYH14 FARS2 ALG3 HARS1 | 2.15e-05 | 654 | 220 | 19 | CID000001023 |
| Drug | europium | 2.17e-05 | 87 | 220 | 7 | CID000023981 | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A | DLG5 ZNF202 PDE10A PHLPP1 FKRP CDK10 VPS13D MYH14 PRKAR1B CFAP44 | 2.31e-05 | 197 | 220 | 10 | 6796_UP |
| Drug | Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.31e-05 | 197 | 220 | 10 | 4658_UP | |
| Drug | cromakalim | 2.34e-05 | 88 | 220 | 7 | CID000071191 | |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | DNAJB12 MTMR2 DNMBP SLC23A2 FN1 INPP5E CEP290 TDRD1 CDK10 ROBO1 | 2.41e-05 | 198 | 220 | 10 | 7235_DN |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Down 200; 100uM; MCF7; HT_HG-U133A_EA | ESR1 PTPRF PIK3CB FGFR2 SLC23A2 RPS6KA4 CDK10 SLC15A2 MYO1F ROBO1 | 2.41e-05 | 198 | 220 | 10 | 881_DN |
| Drug | benzaldehyde | 2.46e-05 | 60 | 220 | 6 | CID000000240 | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A | ATP6V0A1 ESR1 ARIH2 MTMR2 SLC23A2 ENTPD7 MINK1 VPS13D CELSR3 CRBN | 2.52e-05 | 199 | 220 | 10 | 7331_DN |
| Drug | AC1NDT8A | 2.73e-05 | 37 | 220 | 5 | CID004631218 | |
| Drug | 5-HIAL | 2.93e-05 | 19 | 220 | 4 | CID000074688 | |
| Drug | PNP dimethylcarbamate | 3.03e-05 | 7 | 220 | 3 | CID000081656 | |
| Drug | N1-ethylchlorpropamide | 3.03e-05 | 7 | 220 | 3 | CID000362592 | |
| Drug | magnesium | MYH11 MYO1D METAP1D PFKL PDE10A RYR1 TUBB3 PIK3CB ABCC8 FGFR2 ALDH2 ALDH9A1 DNAH5 ITGA11 REM1 PDPR FN1 WRN GRIK3 MSH2 ZDHHC17 GRM5 YES1 GSS GUCY2C FARS2 EIF2S1 ATP5F1A ALDH7A1 | 3.31e-05 | 1325 | 220 | 29 | CID000000888 |
| Drug | DETC-MeSO | 3.55e-05 | 39 | 220 | 5 | CID003035711 | |
| Drug | AC1L1IZ2 | MYH9 MYH10 MYH11 MYO1D RYR1 TUBB3 GK MYH7B GSS MYH14 EIF2S1 ATP5F1A | 4.33e-05 | 304 | 220 | 12 | CID000004795 |
| Drug | perillaldehyde | 4.46e-05 | 21 | 220 | 4 | CID000016441 | |
| Drug | ethylphenyl(2-formylethyl)phosphinate | 4.81e-05 | 8 | 220 | 3 | CID000151185 | |
| Drug | nitrefazole | 4.81e-05 | 8 | 220 | 3 | CID000071900 | |
| Drug | AC1L8X1L | 4.81e-05 | 8 | 220 | 3 | CID000409504 | |
| Drug | N-N-C | 5.12e-05 | 42 | 220 | 5 | CID005278688 | |
| Drug | S-(-)-Etomoxir | 5.35e-05 | 100 | 220 | 7 | CID000060765 | |
| Drug | H-Mn | 6.45e-05 | 71 | 220 | 6 | CID000445522 | |
| Drug | nicorandil | 6.45e-05 | 71 | 220 | 6 | CID000047528 | |
| Drug | AC1NPPZW | 6.46e-05 | 103 | 220 | 7 | CID005183170 | |
| Drug | hydride | HGD ATP6V1E1 SLC36A1 ATP6V0A1 RYR1 ACSL1 SCNN1G ALDH2 ALDH1A3 ALDH9A1 RPS6KA4 H6PD GSS ARG1 HARS2 SLC15A2 GUCY2C MAP4K5 GAN ATP5F1A ALDH7A1 | 6.47e-05 | 835 | 220 | 21 | CID000000783 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.68e-05 | 180 | 220 | 9 | 6454_DN | |
| Drug | beta-alanine | 6.87e-05 | 104 | 220 | 7 | CID000000239 | |
| Drug | AC1NRAX5 | 7.16e-05 | 9 | 220 | 3 | CID005288137 | |
| Drug | MER-25 | 7.16e-05 | 9 | 220 | 3 | CID000006222 | |
| Drug | L 574 | 7.16e-05 | 9 | 220 | 3 | CID000067114 | |
| Drug | aldophosphamide | 7.74e-05 | 24 | 220 | 4 | CID000107744 | |
| Drug | gamma-aminobutyraldehyde | 9.15e-05 | 25 | 220 | 4 | CID000000118 | |
| Drug | cyclic d(ApAp | 9.29e-05 | 2 | 220 | 2 | CID000188955 | |
| Drug | chlorpropamide | 9.83e-05 | 48 | 220 | 5 | CID000002727 | |
| Drug | vernolate | 1.02e-04 | 10 | 220 | 3 | CID000016003 | |
| Drug | NSC85552 | 1.02e-04 | 10 | 220 | 3 | CID003000646 | |
| Drug | Me-DTC | 1.02e-04 | 10 | 220 | 3 | CID000012704 | |
| Drug | resorufin acetate | 1.02e-04 | 10 | 220 | 3 | CID003080579 | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.05e-04 | 191 | 220 | 9 | 5351_DN | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A | 1.09e-04 | 192 | 220 | 9 | 1365_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.14e-04 | 193 | 220 | 9 | 3077_DN | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; MCF7; HT_HG-U133A | DNAJB12 ATP6V0A1 ESR1 ZNF202 ANKRD28 SRSF1 FAAP100 CDK10 MYH14 | 1.18e-04 | 194 | 220 | 9 | 4990_DN |
| Drug | N-nitrosomorpholine | HGD MYO1D FAT1 GK ACSM3 BTG2 PTPRG ALDH2 GSS ARG1 ATP5F1A ALDH7A1 | 1.19e-04 | 338 | 220 | 12 | ctd:C002741 |
| Drug | hippuric acid | 1.20e-04 | 50 | 220 | 5 | CID000000464 | |
| Drug | Tacrolimus | RYR1 FABP2 BTG2 ALDH2 ALDH9A1 EXOSC4 FN1 ACE2 TGM1 TRIB3 ALG3 ARHGAP45 | 1.22e-04 | 339 | 220 | 12 | ctd:D016559 |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.23e-04 | 195 | 220 | 9 | 1053_DN | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; PC3; HT_HG-U133A | 1.23e-04 | 195 | 220 | 9 | 4657_UP | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.28e-04 | 196 | 220 | 9 | 4000_UP | |
| Drug | Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.28e-04 | 196 | 220 | 9 | 4484_UP | |
| Drug | Ribavirin [36791-04-5]; Up 200; 16.4uM; PC3; HT_HG-U133A | 1.28e-04 | 196 | 220 | 9 | 7316_UP | |
| Drug | Colistin sulfate [1264-72-8]; Up 200; 3uM; PC3; HT_HG-U133A | 1.28e-04 | 196 | 220 | 9 | 4212_UP | |
| Drug | Lincomycin hydrochloride [859-18-7]; Down 200; 9uM; MCF7; HT_HG-U133A | ESR1 VPS33A ADGRG1 ANKRD28 PLXNB1 NEMP1 CEP290 CDK10 SLC15A2 | 1.28e-04 | 196 | 220 | 9 | 7411_DN |
| Drug | Nifurtimox [23256-30-6]; Up 200; 14uM; HL60; HT_HG-U133A | 1.33e-04 | 197 | 220 | 9 | 2908_UP | |
| Drug | blebbistatin | 1.37e-04 | 116 | 220 | 7 | CID003476986 | |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.38e-04 | 198 | 220 | 9 | 7497_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.38e-04 | 198 | 220 | 9 | 3723_UP | |
| Drug | Monocrotaline [315-22-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.38e-04 | 198 | 220 | 9 | 2749_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | SUV39H1 ARIH2 SLC23A2 ENTPD7 HDAC6 TDRD1 MAP3K6 PRKAR1B ROBO1 | 1.38e-04 | 198 | 220 | 9 | 983_DN |
| Drug | nitrendipine; Down 200; 10uM; MCF7; HG-U133A | 1.38e-04 | 198 | 220 | 9 | 336_DN | |
| Drug | Butacaine [149-16-6]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.38e-04 | 198 | 220 | 9 | 6225_DN | |
| Drug | Tropine [120-29-6]; Down 200; 28.4uM; MCF7; HT_HG-U133A | 1.38e-04 | 198 | 220 | 9 | 6264_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; HL60; HT_HG-U133A | 1.38e-04 | 198 | 220 | 9 | 2549_UP | |
| Drug | ampal | 1.39e-04 | 11 | 220 | 3 | CID000129385 | |
| Drug | Suramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A | SLC36A1 BTG2 PIK3CB ARIH2 SLC23A2 ENTPD7 MINK1 MAP3K6 CELSR3 | 1.44e-04 | 199 | 220 | 9 | 7496_UP |
| Drug | Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; HL60; HG-U133A | 1.44e-04 | 199 | 220 | 9 | 1442_UP | |
| Drug | Eprosartan-d3 | 1.45e-04 | 28 | 220 | 4 | CID000060878 | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A | 1.49e-04 | 200 | 220 | 9 | 3735_UP | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; HL60; HG-U133A | 1.49e-04 | 200 | 220 | 9 | 1592_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.49e-04 | 200 | 220 | 9 | 3765_UP | |
| Drug | arabinosyladenine | PFKL PDE10A RYR1 PIK3CB ABCC8 KLHL23 SCNN1G FN1 ABCC9 PAF1 GRM5 MADD HARS2 SF3B1 GUCY2C FARS2 SF3B6 HARS1 ALDH7A1 | 1.63e-04 | 762 | 220 | 19 | CID000000191 |
| Drug | Congo red | 1.69e-04 | 120 | 220 | 7 | CID000011313 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.77e-04 | 161 | 220 | 8 | 3556_DN | |
| Drug | AC1L1J0I | 1.84e-04 | 12 | 220 | 3 | CID000030201 | |
| Drug | phenylketophosphamide | 1.84e-04 | 12 | 220 | 3 | CID000127726 | |
| Drug | C13932 | 1.86e-04 | 206 | 220 | 9 | CID000168297 | |
| Disease | aspartate aminotransferase measurement | CFH DLG5 STK35 ITIH1 STN1 ALDH2 ANXA9 DNMBP ENTPD7 FKRP MYH7B CUBN MADD GSS HARS2 CELF1 MAP4K5 RBPJ APOL3 ROBO1 CTSD ARHGAP45 GABBR1 MYBPC3 | 6.01e-08 | 904 | 216 | 24 | EFO_0004736 |
| Disease | Huntington's disease (implicated_via_orthology) | 3.44e-06 | 32 | 216 | 5 | DOID:12858 (implicated_via_orthology) | |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 3.58e-06 | 15 | 216 | 4 | EFO_0006833, EFO_0006896 | |
| Disease | kidney disease (implicated_via_orthology) | 1.21e-05 | 41 | 216 | 5 | DOID:557 (implicated_via_orthology) | |
| Disease | Usher syndrome | 1.33e-05 | 7 | 216 | 3 | cv:C0271097 | |
| Disease | Dupuytren Contracture | 1.52e-05 | 108 | 216 | 7 | EFO_0004229 | |
| Disease | Nonsyndromic genetic hearing loss | 2.05e-05 | 76 | 216 | 6 | cv:C5680182 | |
| Disease | Nonsyndromic Deafness | 2.95e-05 | 81 | 216 | 6 | C3711374 | |
| Disease | lumbar disc degeneration | 4.98e-05 | 28 | 216 | 4 | EFO_0004994 | |
| Disease | ephrin type-a receptor 10 measurement | 5.33e-05 | 2 | 216 | 2 | EFO_0020350 | |
| Disease | USHER SYNDROME, TYPE ID | 5.33e-05 | 2 | 216 | 2 | 601067 | |
| Disease | roundabout homolog 1 measurement | 5.33e-05 | 2 | 216 | 2 | EFO_0803039 | |
| Disease | Usher syndrome type 1D (is_implicated_in) | 5.33e-05 | 2 | 216 | 2 | DOID:0110831 (is_implicated_in) | |
| Disease | Usher syndrome, type 1D | 5.33e-05 | 2 | 216 | 2 | C2931208 | |
| Disease | USHER SYNDROME, TYPE ID | 5.33e-05 | 2 | 216 | 2 | C1832845 | |
| Disease | Usher syndrome type 3B (implicated_via_orthology) | 5.33e-05 | 2 | 216 | 2 | DOID:0110842 (implicated_via_orthology) | |
| Disease | Usher syndrome type 1D | 5.33e-05 | 2 | 216 | 2 | cv:C1832845 | |
| Disease | Charcot-Marie-Tooth disease, axonal type 2W (implicated_via_orthology) | 5.33e-05 | 2 | 216 | 2 | DOID:0110162 (implicated_via_orthology) | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 5.75e-05 | 29 | 216 | 4 | cv:C5779548 | |
| Disease | diet measurement | TDRD15 ESR1 KDM3B TENM2 ACSM3 PTPRF NEGR1 MTMR2 ALDH2 DNAH5 SDK1 GRIK3 GRM5 CELF1 FARS2 MAP4K5 KIAA1217 ROBO1 ZFHX3 IL1R1 | 9.79e-05 | 1049 | 216 | 20 | EFO_0008111 |
| Disease | Hereditary hearing loss and deafness | 1.05e-04 | 146 | 216 | 7 | cv:C0236038 | |
| Disease | severe acute respiratory syndrome, COVID-19 | ADGRG1 TENM2 FBXO10 MTMR2 SLC23A2 MXRA5 WRN MYRIP FARS2 KIAA1217 ZFHX3 CDK11B | 1.24e-04 | 447 | 216 | 12 | EFO_0000694, MONDO_0100096 |
| Disease | cardiovascular disease | TDRD15 EXD1 CHDH PDE10A NEGR1 KCNK3 WRN RASSF10 YES1 ATL1 MAP4K5 MYBPC3 | 1.52e-04 | 457 | 216 | 12 | EFO_0000319 |
| Disease | 6-oxopiperidine-2-carboxylate measurement | 1.59e-04 | 3 | 216 | 2 | EFO_0800066 | |
| Disease | cathepsin D measurement | 1.65e-04 | 15 | 216 | 3 | EFO_0010611 | |
| Disease | obesity (implicated_via_orthology) | 1.97e-04 | 215 | 216 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | body height at birth | 2.08e-04 | 40 | 216 | 4 | EFO_0006784 | |
| Disease | serum alanine aminotransferase measurement | CHL1 CFH DLG5 STN1 KLHL23 ANXA9 DNMBP ENTPD7 MYH7B GRIK3 MAU2 GSS MAP4K5 APOL3 IL1R1 GABBR1 SEMA3E | 2.45e-04 | 869 | 216 | 17 | EFO_0004735 |
| Disease | Familial dilated cardiomyopathy | 3.01e-04 | 44 | 216 | 4 | C0340427 | |
| Disease | sensory peripheral neuropathy (implicated_via_orthology) | 3.17e-04 | 4 | 216 | 2 | DOID:2491 (implicated_via_orthology) | |
| Disease | Elliptocytosis found | 3.17e-04 | 4 | 216 | 2 | C0427480 | |
| Disease | Perrault syndrome (implicated_via_orthology) | 3.17e-04 | 4 | 216 | 2 | DOID:0050857 (implicated_via_orthology) | |
| Disease | Usher Syndrome | 3.17e-04 | 4 | 216 | 2 | C0271097 | |
| Disease | information processing speed | 4.09e-04 | 85 | 216 | 5 | EFO_0004363 | |
| Disease | hereditary spherocytosis (is_implicated_in) | 5.26e-04 | 5 | 216 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | serum alpha-1-antitrypsin measurement | 5.26e-04 | 5 | 216 | 2 | EFO_0005415 | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 5.26e-04 | 5 | 216 | 2 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 5.26e-04 | 5 | 216 | 2 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 5.26e-04 | 5 | 216 | 2 | C1848640 | |
| Disease | Usher syndrome, type 1A | 5.26e-04 | 5 | 216 | 2 | C2931205 | |
| Disease | Hereditary spherocytosis | 5.26e-04 | 5 | 216 | 2 | cv:C0037889 | |
| Disease | palmitoleoyl-linoleoyl-glycerol (16:1/18:2) [1] measurement | 5.26e-04 | 5 | 216 | 2 | EFO_0800504 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 5.26e-04 | 5 | 216 | 2 | C0221409 | |
| Disease | brain infarction (is_implicated_in) | 5.26e-04 | 5 | 216 | 2 | DOID:3454 (is_implicated_in) | |
| Disease | single Ig IL-1-related receptor measurement | 5.26e-04 | 5 | 216 | 2 | EFO_0802072 | |
| Disease | Usher syndrome type 1 | 5.26e-04 | 5 | 216 | 2 | cv:C1568247 | |
| Disease | unipolar depression | CFH ESR1 CSMD3 TENM2 FAT1 PTPRG NEGR1 SDK1 ITGA11 GRIK3 GRM5 TMTC1 SF3B1 MRPL48 ROBO1 ZFHX3 FYB1 CDH9 GABBR1 SEMA3E | 5.95e-04 | 1206 | 216 | 20 | EFO_0003761 |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.11e-04 | 195 | 216 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | gout | 6.29e-04 | 196 | 216 | 7 | EFO_0004274 | |
| Disease | stroke | 6.92e-04 | 144 | 216 | 6 | EFO_0000712 | |
| Disease | smoking cessation | DNAJB12 CSMD3 TENM2 PTPRF PCDH15 RPS6KA4 KIAA1217 ZFHX3 ADAMTSL2 | 6.96e-04 | 325 | 216 | 9 | EFO_0004319 |
| Disease | phospholipase D3 measurement | 7.85e-04 | 6 | 216 | 2 | EFO_0802866 | |
| Disease | Usher Syndrome, Type I | 7.85e-04 | 6 | 216 | 2 | C1568247 | |
| Disease | Elliptocytosis, Hereditary | 7.85e-04 | 6 | 216 | 2 | C0013902 | |
| Disease | MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO | 7.85e-04 | 6 | 216 | 2 | C1832662 | |
| Disease | primary pulmonary hypertension (is_implicated_in) | 7.85e-04 | 6 | 216 | 2 | DOID:14557 (is_implicated_in) | |
| Disease | glycocholenate sulfate measurement | 7.85e-04 | 6 | 216 | 2 | EFO_0800276 | |
| Disease | myocardial infarction (is_implicated_in) | 8.22e-04 | 99 | 216 | 5 | DOID:5844 (is_implicated_in) | |
| Disease | Disorder of eye | 9.97e-04 | 212 | 216 | 7 | C0015397 | |
| Disease | alcohol use disorder measurement | 1.05e-03 | 214 | 216 | 7 | EFO_0009458 | |
| Disease | Hereditary retinal dystrophy | 1.09e-03 | 7 | 216 | 2 | C0154860 | |
| Disease | pleckstrin homology domain-containing family A member 1 measurement | 1.09e-03 | 7 | 216 | 2 | EFO_0802873 | |
| Disease | alcoholic liver cirrhosis (is_implicated_in) | 1.09e-03 | 7 | 216 | 2 | DOID:14018 (is_implicated_in) | |
| Disease | Usher Syndrome, Type III | 1.09e-03 | 7 | 216 | 2 | C1568248 | |
| Disease | interleukin-17 receptor B measurement | 1.09e-03 | 7 | 216 | 2 | EFO_0801719 | |
| Disease | Cleft palate, cleft lip | 1.10e-03 | 279 | 216 | 8 | EFO_0003959, HP_0000175 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.11e-03 | 28 | 216 | 3 | EFO_0000389, EFO_0000621 | |
| Disease | Hyalinosis, Segmental Glomerular | 1.11e-03 | 28 | 216 | 3 | C0086432 | |
| Disease | neuroticism measurement | F13A1 PTPRG NEGR1 SDK1 CLUH TMEM255A NEMP1 RASSF10 GRIK3 GRM5 MADD PWWP2B CELF1 CDH9 GABBR1 SEMA3E | 1.14e-03 | 909 | 216 | 16 | EFO_0007660 |
| Disease | Ciliopathies | 1.32e-03 | 110 | 216 | 5 | C4277690 | |
| Disease | cytoskeleton-associated protein 2 measurement | 1.45e-03 | 8 | 216 | 2 | EFO_0020309 | |
| Disease | Hereditary spherocytosis | 1.45e-03 | 8 | 216 | 2 | C0037889 | |
| Disease | opioid-binding protein/cell adhesion molecule measurement | 1.45e-03 | 8 | 216 | 2 | EFO_0020618 | |
| Disease | hypertension (biomarker_via_orthology) | 1.48e-03 | 227 | 216 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | neuroblastoma | 1.67e-03 | 116 | 216 | 5 | EFO_0000621 | |
| Disease | Intellectual Disability | 1.79e-03 | 447 | 216 | 10 | C3714756 | |
| Disease | Head and Neck Neoplasms | 1.79e-03 | 33 | 216 | 3 | C0018671 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 1.79e-03 | 33 | 216 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | DCN1-like protein 5 measurement | 1.86e-03 | 9 | 216 | 2 | EFO_0801520 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 5 measurement | 1.86e-03 | 9 | 216 | 2 | EFO_0801766 | |
| Disease | glycoprotein measurement | 1.87e-03 | 119 | 216 | 5 | EFO_0004555 | |
| Disease | Endometrial Carcinoma | 1.95e-03 | 72 | 216 | 4 | C0476089 | |
| Disease | Primary dilated cardiomyopathy | 1.96e-03 | 34 | 216 | 3 | cv:C0007193 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.98e-03 | 239 | 216 | 7 | EFO_0010934 | |
| Disease | Colorectal Carcinoma | CHL1 ATP6V1E1 CSMD3 FAT1 ABCC8 SCNN1G ALDH2 FN1 WRN GRIK3 MSH2 CUBN GUCY2C | 2.12e-03 | 702 | 216 | 13 | C0009402 |
| Disease | Bone Diseases | 2.31e-03 | 10 | 216 | 2 | C0005940 | |
| Disease | axin-2 measurement | 2.31e-03 | 10 | 216 | 2 | EFO_0801400 | |
| Disease | thrombosis (implicated_via_orthology) | 2.31e-03 | 10 | 216 | 2 | DOID:0060903 (implicated_via_orthology) | |
| Disease | level of Sterol ester (27:1/18:3) in blood serum | 2.31e-03 | 10 | 216 | 2 | OBA_2045193 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 2.31e-03 | 10 | 216 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Fuchs endothelial corneal dystrophy | 2.31e-03 | 10 | 216 | 2 | Orphanet_98974 | |
| Disease | multimerin-2 measurement | 2.31e-03 | 10 | 216 | 2 | EFO_0801809 | |
| Disease | Head and Neck Carcinoma | 2.31e-03 | 10 | 216 | 2 | C3887461 | |
| Disease | Focal glomerulosclerosis | 2.31e-03 | 36 | 216 | 3 | C0017668 | |
| Disease | melanoma | 2.39e-03 | 126 | 216 | 5 | EFO_0000756 | |
| Disease | calcium measurement | CFH ITIH1 HEPH DMBT1 MAP4K3 MAU2 ATL1 SLC15A2 MAP4K5 RBPJ ZFHX3 HCLS1 | 2.42e-03 | 628 | 216 | 12 | EFO_0004838 |
| Disease | Combined oxidative phosphorylation deficiency | 2.50e-03 | 37 | 216 | 3 | cv:C4540031 | |
| Disease | Renal Cell Carcinoma | 2.56e-03 | 128 | 216 | 5 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.56e-03 | 128 | 216 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.56e-03 | 128 | 216 | 5 | C1266042 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AEGYYRVNIGEVLDK | 671 | Q13523 | |
| IDILDQYARVGEEYQ | 86 | P23470 | |
| SVLVGYVDYGNFEIL | 571 | Q9BXT4 | |
| QGTGGRLLIDEYYNE | 296 | P16452 | |
| GRENGRVTIEYYSQL | 466 | P49189 | |
| VQVLYGGTDLFDYEV | 441 | Q9P2K9 | |
| GQVIGENYGYRDTVV | 2826 | Q7Z407 | |
| EVQEYVDICDYAVGL | 146 | P49419 | |
| YDDVTTLYEGFQRGI | 86 | P33121 | |
| FEQYGAVYEINVLRD | 36 | Q92879 | |
| AEVEGVINGTYDYTQ | 76 | Q92685 | |
| GDELVQTYVYEGVEA | 111 | P12104 | |
| YDRIVLFPGVYEEQG | 131 | Q9UK96 | |
| GRELGEYALAEYTEV | 486 | P47895 | |
| IGGEQEYLYTDVDEL | 1031 | O15084 | |
| IYAYREEQDFGIEIV | 141 | Q96SW2 | |
| EEEPGTYGVALYRFQ | 241 | Q6XZF7 | |
| ASYYVTIETGINLRG | 371 | O60706 | |
| QTGLELYEGYGQTEV | 361 | P0C7M7 | |
| EDYYVGVASDVEQQG | 36 | O95376 | |
| LNRIEEGTYGVVYRA | 441 | P21127 | |
| EGYQLLGEINYRECD | 116 | P08603 | |
| EVRYVIDYYDGGEVN | 221 | P53701 | |
| GVSEGQFRQVLYYEL | 671 | Q9H9G7 | |
| SREYGQESIIYSLEG | 701 | Q9H251 | |
| DIGINSVLSYYITEG | 1556 | Q9H251 | |
| YEGEVITVGSDGYVR | 376 | Q96MT7 | |
| IEEQVAVIYAGVRGY | 481 | P25705 | |
| GLTYREGLYITEEIY | 251 | P05089 | |
| ESRDEYSYVVVGAGS | 36 | Q8NE62 | |
| YRGVELLGYSEAAVR | 471 | A0A1B0GUU1 | |
| NYVQDTYLVGAGIEL | 271 | A6NK89 | |
| ELVERFALYGAIEQY | 61 | Q5RL73 | |
| GDVYSYGIIAQEIIL | 661 | P25092 | |
| ILQDGEDYQYIERGE | 621 | Q0ZGT2 | |
| YGDGDIYNIVRVRSL | 596 | Q6IE37 | |
| EYREYGATVSEDILV | 3231 | Q14517 | |
| VLYIRNVTFEDAGEY | 326 | P21802 | |
| IDIYVQVLQADGGTY | 121 | Q9NPD3 | |
| RDQYLIFGAEEGIYT | 571 | Q8IVH8 | |
| YDVTDGYQREAVGGI | 311 | P41594 | |
| YLEAGEAVVYPLQEA | 1001 | Q92619 | |
| DGDIINIDVTVYYNG | 171 | Q6UB28 | |
| EDVSQRVYLYEGLLG | 1276 | Q8WXG6 | |
| QYLDIYGITRDQAGE | 186 | Q7Z3B1 | |
| DVIETRGREYAGLYD | 1061 | O00533 | |
| RGREYAGLYDDISTQ | 1066 | O00533 | |
| QYERYLARVGELEAT | 61 | Q9NQZ7 | |
| EADYAQDLYVIGVQE | 326 | Q9NRR6 | |
| KQYYEGSEIVVAGRI | 501 | P19827 | |
| RYNLSQGGYEELERV | 51 | O14649 | |
| YEIEYVCRGEREVVG | 61 | Q9UBS5 | |
| IRADIEVACYGYEGI | 191 | P05198 | |
| LTTLVDGYLNTYREG | 271 | Q8NHP7 | |
| RLVEVDSGRQIEYEY | 226 | P20700 | |
| FDYEYTETGERLVLG | 641 | O95382 | |
| EELYIGVTVNVNGYL | 506 | Q5JST6 | |
| YPEEEQLSGAGYRVS | 111 | Q9Y6B2 | |
| DVAGYIVGANIETYL | 271 | Q7Z406 | |
| VSELGESARYLRQGY | 46 | A7E2Y1 | |
| YTREGRAEDGTEVAY | 341 | O43157 | |
| YLENEPSGYTVREAG | 131 | P03372 | |
| NRGEYEIDIAGYRFQ | 836 | Q8NCN5 | |
| YELNSYIEQRLDTGG | 76 | Q9Y233 | |
| YEGVLQLVEARGRYE | 501 | P17858 | |
| QEYGLGSIIAQDEIY | 406 | O14524 | |
| GYVLRSYLADNDGEI | 756 | O15117 | |
| LEQEYSRYFTGVIQG | 1876 | Q8TDM6 | |
| SVAGGAVYLVYDQEL | 16 | Q5XKP0 | |
| ELARYGGEEEDQPIY | 51 | Q9UMX5 | |
| YNAYGLITAEDRRVG | 1541 | Q7LBC6 | |
| RLGYDDYVQVYEGLG | 301 | O75074 | |
| DYVQVYEGLGERGDR | 306 | O75074 | |
| GSVYRAAYEGEEVAV | 1891 | Q5S007 | |
| LTISRVEAGDEADYY | 91 | P80748 | |
| DGYYRTIRGFEVLVE | 436 | Q13614 | |
| DVYETGIEYIVAQGP | 291 | Q86TH1 | |
| EREEYVLNDIGVIFY | 201 | P00488 | |
| QYFKEAEVRVYGGEI | 131 | O75676 | |
| NGYIVGANIETYLLE | 246 | P35579 | |
| GRDSYSGIIDYNLAE | 186 | O76027 | |
| FNEGRERGKVYVYEL | 506 | Q9UKX5 | |
| FNVYYLETEADLGRG | 126 | Q5JZY3 | |
| VGEEVYGIQIYTLDE | 846 | Q13219 | |
| QIERELDEGRYGVYE | 231 | O15541 | |
| SELVYVYDQEGGLLT | 41 | Q0VG06 | |
| ETVDGYRRYFTQIVG | 326 | Q8TAG9 | |
| YVNLERLGYSEDGLE | 571 | Q9P2V4 | |
| KGVRVRALYDYDGQE | 386 | Q9BY11 | |
| SYFSEEGIGYNIIRV | 146 | P04062 | |
| PITDERVYESIGQYG | 236 | Q8N3R9 | |
| GTEVRVRALYDYEGQ | 426 | Q9UNF0 | |
| VRDYYELVVVATDGA | 781 | Q96QU1 | |
| REGDGVYYNELETRV | 316 | Q8N7H5 | |
| EEAIGNYYTDFLEIR | 1096 | O60494 | |
| YGTYAEEEGLRARLQ | 741 | O75054 | |
| VYYNTDDEREGGSVL | 496 | Q6ISB3 | |
| QGAEIPDYTRESYGV | 301 | Q8NBE8 | |
| YREAETEAFLTYIEG | 236 | P48547 | |
| RTGVGAAVIDNYLYV | 516 | Q9NXS3 | |
| YSGEYRELGAVIDQV | 496 | Q8WXF7 | |
| GVYYQIGDVVSVIDE | 146 | Q8WUU5 | |
| GEGTYGIVYRARDTQ | 46 | Q15131 | |
| YESGVYGLEDAVVEI | 451 | O15078 | |
| GVEYVYTIQVLRDGQ | 1146 | P02751 | |
| EGQQYVEAGTYIVLE | 456 | Q5T0N1 | |
| FRIVLTAVGGESIYY | 31 | P36383 | |
| VIGDLDTGTNYDYVR | 531 | Q9H2C0 | |
| GDVFIGRYYTVFDRD | 386 | P07339 | |
| RVTDHLGVVYYVGDT | 286 | Q9NXW2 | |
| DGSQYYVLLIITDGV | 421 | Q8IYJ1 | |
| LEREITFQGDSAIYY | 86 | Q7Z388 | |
| YYALEGSVAIAGAVI | 321 | P32189 | |
| GVDGYDYSRGQLIED | 211 | Q9BYF1 | |
| EGYNLYRLVVEVFGT | 496 | Q9Y653 | |
| ENVSGYYADARLEVG | 41 | O95236 | |
| YQVVLGEYDRAVKEG | 81 | P08861 | |
| TYYEGEEVNAGRIGL | 361 | Q9Y5Y0 | |
| GREEVEYYQSEAEGL | 171 | Q96A59 | |
| SGDYYVTVVEDVTLG | 81 | Q96EK6 | |
| GDNFYVVDQGEVDVY | 171 | P31321 | |
| VEGTGYAGNIYRDLV | 456 | Q5T1A1 | |
| EGELRVLADTYDSVY | 161 | Q9UBN7 | |
| ARYVVGVLEAAGVRY | 326 | Q9H9S5 | |
| YDVDLGIYLEDVGNC | 361 | Q9H9S5 | |
| AQYRETLRENVEEGY | 436 | Q9NYQ7 | |
| LYDVGYRDIVNIDIS | 66 | Q8N6R0 | |
| EYYRLAVDALAEGGS | 26 | Q6ZRV2 | |
| VDGQEIAVVYFRDGY | 256 | P48637 | |
| EYLEYRRIVGEDDGG | 16 | A4D161 | |
| YEIRLVEDGKYGAQD | 481 | Q13003 | |
| DAEGRTSFYEEYGVI | 246 | O95479 | |
| TSFYEEYGVIRDVLQ | 251 | O95479 | |
| RDVQLEGGCNYDYIE | 2051 | Q9UGM3 | |
| EPVYRAELVGELNGY | 346 | Q6NUJ5 | |
| GVTYEFRVVAVNEAG | 1971 | Q7Z5N4 | |
| EDYGVSAYRTVQRGE | 541 | Q16348 | |
| GSEYGLQVILYINEE | 301 | P51170 | |
| GAEYARVVGSEYTRA | 171 | Q9Y6X3 | |
| DSDDQRRLVYYEGGA | 236 | P21817 | |
| AGDEYELYRVVFDIT | 4906 | P21817 | |
| FLLEEYTGTDTQYVG | 61 | Q9ULB4 | |
| RGLDYYTGVIYEAVL | 326 | P12081 | |
| YGRDDYVGEDIVEVI | 426 | P14778 | |
| LEEFQYIGESQGYDI | 851 | P43246 | |
| DVTGYIVGANIETYL | 251 | P35580 | |
| IGEIQYGGRVTDDYD | 4246 | Q8TE73 | |
| VGDGQRIYLVTTYAE | 71 | Q96LW4 | |
| ELVQRVGSGTYGDVY | 21 | Q9Y4K4 | |
| QYSVAYEAVDGEDRG | 641 | P10586 | |
| IRGYQVTYVRLENGE | 741 | P10586 | |
| AEFVEEYGVVDGIYR | 41 | Q7Z6I6 | |
| AYVIVYSIADRGSFE | 156 | O75628 | |
| DVFEETRGYILEVYG | 191 | Q93099 | |
| EDEGVYVNTYGRIIK | 1231 | Q8N4C8 | |
| VRNAEDIEQLYGKGY | 51 | Q8NCE0 | |
| GTVIGVRERDAFYSY | 61 | Q9H668 | |
| GTGALIYVIDAQDDY | 136 | Q9HB90 | |
| ARGLDYYTGVIYEAV | 326 | P49590 | |
| IYRAFVDVVNGEYVP | 391 | O94763 | |
| VDGVSYLLQEIYGIE | 241 | Q96PX1 | |
| IYYELGEDTIRQAFA | 136 | Q9UHX1 | |
| RVEITGGYYEYIDVS | 196 | Q5JRV8 | |
| GDLVVAEYSGDNAIY | 1346 | B5MCY1 | |
| ISAVAVYDYQGEGSD | 431 | P14317 | |
| AYIIIESREEGASDY | 381 | Q9NPR9 | |
| TDGATRVYYLGIRDV | 21 | Q9BQS7 | |
| IREVGRGSYGVVYEA | 11 | Q8N165 | |
| GYDSEQVDGILYTVL | 916 | Q8TE76 | |
| ERSLGVLYLQYGDET | 181 | Q5T5P2 | |
| EVRAINLGTDYEYGV | 76 | Q96GC5 | |
| AYGQRVYGLSDAVVS | 1131 | Q9NT68 | |
| ETCVVVYTGYGNREE | 121 | Q16637 | |
| ESYYQEIGRAGRDGL | 846 | Q14191 | |
| VGAYDADVDIRDYSG | 361 | Q53LP3 | |
| ILTNGLVSVYELDYG | 981 | Q8NHU6 | |
| YVLQVSGRVEYVFGD | 246 | P42338 | |
| VYINEYRVGEGITLN | 161 | O43463 | |
| DEIYEGEYQGIPRAE | 91 | Q7L0J3 | |
| SYYVAIETGINLRGA | 376 | Q09428 | |
| YRIGEDGSICVLYEE | 111 | P78543 | |
| GRELGEYGLQAYTEV | 491 | P05091 | |
| DIYEGYGQTETVLIC | 371 | Q53FZ2 | |
| GTVVVDYRGYRVTAQ | 471 | O75153 | |
| DVTGYIVGANIETYL | 251 | P35749 | |
| ADVHNGIRGEIYYRE | 101 | O75443 | |
| VGYIRVRFYEGSELV | 891 | P35443 | |
| LEIQAGIYLEGSIYE | 21 | Q8N1K5 | |
| AEIGRGSYGVVYEAV | 206 | Q8TDR2 | |
| QLFSVGVRDSGYYVI | 106 | A8MXK1 | |
| GVRDSGYYVITVTER | 111 | A8MXK1 | |
| YYEDGAFGIRIENVV | 526 | Q9NQW7 | |
| TGRYEEALQIYQEAA | 696 | Q8IUR5 | |
| VGFVVGTYEALYELI | 446 | Q7Z2H8 | |
| AVVASIIESIGDYYA | 386 | Q9UGH3 | |
| YDFLVEVEGDNRYIA | 346 | P04844 | |
| DYYARVEGREIISNL | 586 | O75533 | |
| RYEVYGGENEVIPEV | 606 | Q6ZVD7 | |
| YVLLEPEEGGRAYQA | 71 | Q96RU7 | |
| TRGTAYVVYEDIFDA | 56 | Q9Y3B4 | |
| DYVRVTQLYCDGVGV | 36 | P53804 | |
| YVGDSDLQLERISVY | 36 | Q13509 | |
| VIGGATYEEALTVYN | 506 | Q9NRW7 | |
| DEGVYVCVARNYLGE | 141 | Q9Y6N7 | |
| RYFYTGAEILGLIDE | 1801 | P11277 | |
| FYGETAAVYVAVEER | 551 | P01833 | |
| DGVYQVVEYSEISLA | 296 | Q16222 | |
| EGEEFTVRDGYIHYG | 231 | Q06330 | |
| QYGIYERCRELVEAG | 66 | Q8IUH5 | |
| VGGEDYEEVDRYSRQ | 301 | Q86UK7 | |
| NIVDAYGIGTYREIN | 376 | Q93050 | |
| GRFINAEYTEEAYEG | 201 | Q8NET8 | |
| YGVFDGDRNVEVPYL | 1206 | O60346 | |
| YQERLFVGGRDLVYS | 66 | O15041 | |
| NLVEFTDEEGYGRYL | 126 | Q12874 | |
| DVCYADVYRDGTGVV | 146 | Q07955 | |
| ESGRIYYGTEAQIGE | 271 | P22735 | |
| SYLPEDIAGGVEIYN | 171 | P36543 | |
| ATQLTYEGLIDEIYG | 241 | Q96AX1 | |
| SQVYGAVAERLREYG | 276 | Q8IWY8 | |
| YAENDFYDLVRTIGG | 376 | O95363 | |
| LVEERGLEYTGIYRV | 1171 | Q5T5U3 | |
| FYGEYVLEEDCGIVV | 261 | O95125 | |
| GEIVYQPDGSAYIVE | 131 | Q15911 | |
| GGVTIFVALYDYEAR | 91 | P07947 | |
| SVGYENIISDIGYFE | 1241 | Q5THJ4 | |
| NIYGRDTIEQYKGRE | 56 | O94832 | |
| PQEEYSIGVLDIYGF | 376 | O00160 | |
| ADEEALYYTGVRAQI | 411 | Q9NR99 | |
| YEAQDVYSGDIISGL | 366 | P17050 | |
| SEYERIAFQYGVTDL | 331 | Q14896 | |
| SLEENVYLAAGTVYG | 696 | Q8NFW9 |